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Abstract 
Calcium oxalate (CaOx) is the most common component of human kidney stones. 
Heterogeneous nucleation is regarded as the key mechanism in this process. As such, 
crystallization of this substance has been studied in several different model systems. 
However, molecular imprinting has not been previously used in this field. In the present 
study, template crystals of calcium oxalate mono- and di-hydrate (COM and COD 
respectively) were used to imprint a copolymer of 6-methacrylamidohexanoic acid and 
divinylbenzene. Thereafter, the imprinted polymer was immersed in three different test 
solutions in an attempt to nucleate CaOx crystal formation. The test solutions were 
different concentrations of aqueous solutions of calcium chloride and sodium oxalate an 
artificial urine with varying magnesium and citrate concentrations and a sample of real 
urine. The crystals formed were characterized by X-ray powder diffraction, Fourier 
transform infrared spectroscopy, atomic absorption spectroscopy and scanning electron 
microscopy. Results showed that in the aqueous solution, the COM imprinted polymer 
specifically induced the nucleation of COM only. However, the COD-imprinted polymer 
induced only trace amounts of COD and large amounts of COM. In artificial and real 
urines, calcium phosphate formed spontaneously (attributed to high pH) in cases where no 
polymer was added and in the presence of the unimprinted polymer (control). The COM 
imprinted polymer precipitated pure COM crystals in some cases and a mixture of COM 
and calcium phosphate in others. The COD imprinted polymer, however, precipitated 
calcium phosphate with trace amounts of all three hydrates of calcium oxalate. Trace 
amounts of COD and large amounts of calcium phosphate precipitated only in cases where 
the magnesium and citrate concentrations of the artificial urine were reduced. In the urine 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
III 
samples from healthy white South African male subjects, calcium phosphate precipitated 
when no polymer was added and in the presence of control polymer. This study provides 
evidence that the imprinted polymers direct formation of their morphologically-matched 
crystals and that rapid hydrate transformation of COD to COM might have occurred. 
Further, the study supports the hypothesis that heterogeneous nucleation plays a key role in 
CaOx stone formation and that the imprinted polymer model may provide an additional 
and superior diagnostic tool for stone researchers to assess stone-risk in urine. 
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CHAPTER ONE - KIDNEY STONE DISEASE 
1.1. What are renal calculi? 
The urinary tract consists of kidneys, ureters, bladder and urethra. Renal calculus can 
occur anywhere within this tract. Kidney stones are the most common. The disease in 
which urinary calculi are formed is called urolithiasis. This is a process in which 
crystals are retained somewhere in the urinary tract to further grow and aggregate and 
cause disease. Crystalluria on the other hand, is a process in which small crystals are 
flushed out of the kidney without causing harm. Crystalluria is a common event for 
both stone-formers and non-stone-formers (Hess and Kok, 1996). Kidney stones are 
composed of CaOx, calcium phosphate, uric acid, cystine, magnesium phosphate (table 
1) or other insoluble salts (Sutor and Scheidt, 1968; Daudon et aT., 1993; Ramello et al., 
2000). The biomineralization of CaOx is of considerable interest, as it is the most 
common constituent of kidney stones. There are three hydrates of CaOx: calcium 
oxalate monohydrate (COM), calcium oxalate dihydrate (COD) and calcium oxalate 
trihydtare (COT) (Brecevic et at.. 1986). Of these, the first is the most stable 
thermodynamically (Grases et aI., 1990). COT IS very rare in urine as it is 
thermodynamically unstable (Grases et at., 1998). 
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Table 1.1. Common types of kidney stones and their relative incidence (Bullock 
et al., 1998). 
Pure calcium oxalate 45% 
Calcium oxalate + phosphate 25% 
Magnesium phosphate 20% 
Calcium phosphate 3% 
Uric acid 5% 
Cystine 3% 
Although there has been much research on this disease, the mechanism of stone 
formation is not completely understood. Attempts to control the mechanism by which 
crystallization in urine proceeds and hence provide insights into how kidney stone 
disease might be managed have not been entirely successfuL No one has formulated an 
efficient prevention and cure procedure. The complexity of urine and the environment 
of the kidney mean that kidney stone disease is multifactoriaL 
1.2. Epidemiological factors 
Stone disease has been known to be common since Hippocrates' times. "Stone waves" 
were seen during world wars I and II in the involved European countries. This was 
probably related to dietary deficiency (Prien, 1971). Diet, race, sex and age, climate, 
profession, geographic location and fluid intake are some of the factors that affect the 
epidemiology of nephrolithiasis (Rose and Westbury, 1979; Scott, 1985; Sakhaee et aI., 
1987; Beukes et aI., 1987; Rodgers, 1991; Ramello et aI., 2000). 
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1.2.1. Geography 
Some countries have "stone belts", for example, there is one in the United States that 
stretches through the south east of the country. People who live in this belt (Florida, 
Georgia, South Carolina and North Carolina) show a higher incidence of urolithiasis 
than those living in the rest of the United States (Boyce and Strawcutter, 1956). 
1.2.2. Race 
Several studies have shown that irrespective of the geographical area concerned, 
prevalence of kidney stone disease is higher in whites than in blacks (Reaser, 1935; 
Modlin, 1967~ Robertson and Peacock, 1981). In South Africa, ] 0-15% of the white 
population form stones whereas in blacks the prevalence is <1 % (Modlin, 1967; 
Whalley et aI., 1998). The chemical composition of urine from non stone-forming 
blacks and whites is different (Goodman et aI., 1995). Compared to whites, South 
African blacks have lower urinary calcium levels resulting from less calcium intake. In 
USA and Brazil, the ratio of white to black stone-formers is four-to-one (Ramello et al., 
2000). African blacks are reported to have higher urinary citrate excretion due to poor 
metabolic rate of circulating estrogens because of nutritional liver damage (Soucie 
et ai., 1994). As the African Americans changed their dietary habits to that of the 
Caucasians, an increased incidence of urolithiasis was observed (Robertson and 
Peacock, 1981). This loss of immunity was not originally observed in the black South 
Africans, possibly because they clung to their tribal dietary habits even when they 
moved to industrial areas (Modlin, 1967). However, more recent reports have suggested 
that the loss of immunity is beginning to be observed in urban blacks in South Africa 
where stone incidence has started to occur, but at a very low level (Whalley et al., 
1999). 
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1.2.3. Age and sex 
The male-to-female ratios reported from all white population studies are greater than 
one (i.e. 1 :3). Sex hormones are suggested to playa role in this ditIerence (Iguchi et at., 
1999). Also, men generally have larger body mass and hence larger amount of material 
to excrete (Blacklock, 1982; Hess and Kok, 1996). The peak age of occurrence in men 
is 35 years while in women, a double distribution peak appears at 30 and 55 years; the 
latter peak is suggested to be due to menopausal bone reabsorption (Blacklock, 1982; 
Fan eta/., 1999). In industrialized countries, 5.9 to 12.5 percent of men and 3.7 to 5 
percent of women suffer from urolithiasis during their lifetime (Ramello et al., 2000). 
1.2.4. Climate 
CaOx urolithiasis is generally common in areas with a hot climate (Bateson, 1973; 
Robertson etal., 1974; Hallson and Rose, 1975; Robertson eta/., 1975). This is 
suggested to be due to high supersaturation of urine with respect to calcium and 
oxalate, lower urinary pH and smaller urinary volume resulting from enhanced loss of 
liquid by sweating (Schwille and Herrmann, 1992). Saudi Arabia for example is the 
country with the highest occurrence of urolithiasis ever reported (Robertson and 
Hughes, 1994). About 21 % of Saudi Arabians suffer from urolithiasis at sometime in 
their life time. Seasonal changes bring about changes in urinary biochemistry 
(Robertson et a/. 1975). It is reported that in some European countries and the United 
States, the occurrence of stones is higher during the warmer seasons (Schwille and 
Herrmann, 1992). Some studies reported an increase in the incidence of urinary calculi 
in American and German soldiers assigned to the desert (Blacklock, 1982). 
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1.2.5. Profession 
Many studies have reported that a high risk of urolithiasis is associated with sedentary 
occupations. For example, airline pilots, accountants, clerks and bus drivers have high 
risk of kidney stone formation compared with people involved in jobs with more 
physical activity like farmers and forestry workers (Blacklock, 1982; Robertson and 
Peacock, 1983; Rodgers, 1991). Compared to ground service ( ego drivers), pilots are 
reported to be more susceptible to stone disease probably due to the more sedentary 
nature of their work and lower intake of water before and during their flight 
(Garilevich, 1995; Ramello, 2000). Other studies have also reported a high prevalence 
of urolithiasis in workers exposed to a hot environment and massive sweating (pin 
et ai., 1992; Ramello et aI., 2000). Thus, chronic dehydration is an important risk factor 
of stone disease. 
1.3. Physicochemical aspects of calcium oxalate stone formation 
1.3.1. Calcium 
As a constituent of CaOx, calcium is an important risk factor because it directly affects 
the supersaturation of urine with respect to CaOx (Massey et al., 1993). A high stone 
occurrence is usually associated with a raised calcium excretion (Giannini et al., 1999). 
Hypercalciuria is the term used for abnormally high calcium excretion in the urine but 
since the upper normal limit of calcium is different for different geographical locations, 
the cause tor calcium stone disease is most often called as idiopathic hypercalciuria 
(Ryall, 1989; Hess and Kok, 1996). There is a significantly higher incidence of 
idiopathic hyperca1ciuria in stone-formers compared to the normal subjects of matched 
age and sex (Pak, 1998). 
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1.3.2. Oxalate 
Oxalate, a dicarboxylate anion which fOID1S insoluble CaOx salt with calcium in urine, 
is more influential than calcium in determining the risk of kidney stone formation 
(Robertson and Peacock, 1983; Ryall, 1989). This is because urinary oxalate brings 
about a more significant change in the supersaturation of urine with respect to CaOx 
than calcium, making oxalate playa more determining role (Robertson, 1999; Rodgers 
and Lewandowski, 2002). Studies have shown that compared to healthy controls, stone-
formers have higher urinary oxalate levels (Wilson et aI., 1989). 
1.3.3. Uric acid 
Uric acid if present in excess can promote CaOx crystallization by epitaxy and possibly 
by interfering with the inhibitors in the urine (Robertson et a!., 1978). For example, 
colloidal particles of urate can bind glycosaminoglycans (GAG) and reduce their 
inhibitory potency and consequently enhance nucleation, growth and aggregation of 
CaOx crystals (Grover and Ryall, 1995) 
1.3.4. pH 
pH is an important risk factor because it changes the ionization of urinary inhibitors and 
the solubility of CaOx crystals (Tiselius, 1981). Urinary pH for healthy persons varies 
over the entire physiological range (4.5 to 8.4) whereas stone-formers do have 
relatively narrow pH ranges (Tietz, 1976). It is interesting that the physicochemical 
system of urine from stone-formers shows buffer properties due to the precipitated 
calculi (Bilobrov et aI., 1990). Sodium pyrophosphate, chondroitin and citrate are 
commonly used to inhibit CaOx crystal gro\\<1h by increasing urinary pH. Sodium 
pyrophosphate is the best because it raises the pH significantly. The effect of pH on 
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inhibition is strongly dependent on the contribution of different urmary inhibitors 
present in the urine (Tiselius, 1981). 
1.3.5. Urinary volume 
Urinary volume is the most influential of all the risk factors (Ryall, 1989). The advice 
to drink more liquid as a treatment for urinary stone disease has been appreciated since 
Hippocrates' times. Increasing urine volume by increased fluid intake lowers the 
likelihood of stone recurrence (Curhan et aI., 1996). Although it needs to be 
accompanied by dietary modification and drugs, high fluid intake alone can be taken as 
a treatment to inhibit stone recurrence in single stone-formers (Pak, 1999). High intake 
of fluid dilutes the urine, lowers the concentration of stone forming ions, and thereby 
reduces the probability of stone formation (Ryall, 1989), The higher the fluid intake, 
the more dilute the urine and the lower the incidence of stone disease. 
1.3.6. Supersaturation 
Supersaturation is a prerequisite for crystallization and is the thermodynamic driving 
force for stone fommtion (Lingeman et ai, 1999). Supersaturation is a concentration 
product or activity product above the solubility product or equilibrium activity product 
(Hess and Kok, 1996). The free energy of CaOx stone formation is given by 
L'.G RT In AI Ao - - - - - - -I . - - - - - (1) 
where R is the gas constant, T is the temperature, and Ai and Ao are activities of the 
unionized salt species at any gIven condition and at equilibrium respectively 
(Finlayson, 1978). It must be noted that the presence of a salt mixture and 
co-precipitation have significant effect on the thennodynamic solubility constant 
(Lingeman et af., 1999). The state of urinary saturation with respect to CaOx can also 
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be computed using the computer program, EQUIL, formulated by Finlayson (1977). 
This program can be used to calculate relative supersaturation of urine based on the pH 
and total concentrations of sodium, potassium, calcium, magnesium, uric acid, chloride, 
ammonium, citrate, phosphate, sulphate, oxalate, pyrophosphate and carbon dioxide 
(Werness et al., 1985). 
The ratio of the actual concentration product or activity product to the solubility 
product or equilibrium activity product (Ai Ao) is also referred to as relative 
supersaturation (RS) (Hess and Kok, 1996). At RS values <1, urine is said to be 
undersaturated, a condition under which no precipitation nor crystallization can occur 
and any stones in the solution can dissolve. Urine is saturated at RS value equal to 1, 
where existing stones will not dissolve or grow and no new stones will be formed; 
however existing stones can aggregate. The solubility product (SP) is the concentration 
at which the RS is exactly equal to 1 (figure 1). Urine is supersaturated at RS values> 1. 
Under this condition, existing stones may grow but no precipitation occurs unless the 
upper limit of metastable limit (also called formation product, FP) is exceeded. 
(Robertson et al., 1968; Nancollas and Gardner, 1974; Finlayson, 1978; Hess and Kok, 
1996). Supersaturation has two stages; the metastable and unstable stages. The 
metastable stage, a level between SP and FP (figure 1), is one in which crystallization 
does not take place unless seed crystals or other foreign surfaces are added to disturb 
the stability or lower the level of formation product (FP* and FP', figure 1). Secondary 
nucleation refers to the process where crystals nucleate on the surface of crystals of 
their own species whereas in epitaxy, crystals are precipitated on the surface of other 
crystals with identical lattice dimensions (Hess and Kok, 1996). In the case of the 
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unstable stage, a level beyond FP (figure 1), there occurs spontaneous crystallization 
(or homogeneous nucleation) (Kavanagh, 1992). 
A 
Pure solution 
B 
Solution with 
CaOx crystals 
C 
Whole urine 
RELATIVE SUPERSATURATION ----..... 
4-6 80-100 
metastable 
SP FP* FP' FP 
Figure 1. Relative supersaturation and CaOx crystal nucleation. A: perfectly 
clear aqueous solution of CaOx. B: Perfectly clear aqueous solution containing 
CaOx crystals. C: Whole urine containing foreign surfaces and crystals [Hess 
and Kok, 1996]. 
1.4. Dietary factors 
Diet is an important urolithiasis risk factor because it influences urinary composition. 
Thus, any diet which affects the key urinary risk factors - calcium, oxalate, uric acid, 
citrate, pH and volume - is of significance (Vahlensieck, 1986; Hesse et aI., 1993; 
Hess, 1996; Hess et at., 1998; Giannini et aI., 1999; Lewandowski et ai, 2001). 
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1.4.1. Calcium 
Diet containing dairy products, meat, fish and poultry are rich in calcium (Massey 
et ai., 1993). In normal individuals, only 6% of the dietary calcium appears in the urine 
(Goldfarb, 1994). Patients with hypercalciuric urolithiasis have increased 
gastrointestinal calcium absorption. Dietary calcium has been regarded as a risk factor 
for stones because it raises the urinary excretion of calcium (Curhan et aI., 1993). As 
such in the past, doctors frequently advised people with a history of CaOx stones to 
reduce their calcium consumption. However, recent studies note that calcium restriction 
is not a good therapy for CaOx stone-formers and even potentially dangerous (Curhan, 
1997; Moyad, 2003). Negative body (eg. bone) calcium balance and high oxalate 
excretion due to reduced intestinal binding of oxalate are the main consequences of low 
calcium intake especially if accompanied by high protein intake (Goldfarb, 1994; Hess, 
1996; Hirvonen et ai., 1999). Therefore, diet containing moderate amounts of calcium 
and oxalate accompanied by a high fluid intake is now recommended for lowering the 
risk of urolithiasis (Hesse et al., 1993). 
1.4.2. Oxalate 
Abnormally high levels of urinary oxalate (also called hyperoxaluria) can come from 
foodstufT as well as from metabolic pathways (Hesse et ai., 1993; Goldfarb, 1994). 
Earlier reports (Finch et aI., 1981) suggested that dietary oxalate makes 10-20% of 
urinary oxalate excretion while later reports (Holmes and Assimos, 1999) suggested the 
contribution of dietary oxalate to urinary oxalate excretion to be up to 40%. Oxalate-
rich foodstuff include: rhubarb, spinach, beetroot, peanuts, chocolate and black tea 
(Massey et aI., 1993). Most of urinary oxalate excretion comes from metabolic activity 
(Massey et aL 1993). Oxalobacterformigenes is one of the anaerobic microflora of the 
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human intestine responsible for degrading oxalate (Massey et a!., 1993). Lower 
quantity and activity of oxalate degrading bacteria may be the possible explanation for 
the relatively higher oxalate excretion in South African blacks compared to the white 
population but this has not yet been explored (Lewandowski et a!., 2001). 
1.4.3. Protein 
High animal protein intake can increase urinary excretion of CaOx and uric acid and 
hence it can increase the prevalence of urolithiasis (Robertson et a!., 1979a; Curhan, 
1997; Hess et al., 1999; Giannini et aI., 1999; Hess, 2002). Hypertension and obesity 
have been reported to be possible stone risk factors (Goldfarb, 1994). Both are related 
to a rich diet with high animal protein intake. The increase in calcium and oxalate 
excretion due to increased resorption and oxalate metabolism respectively are more 
significant in animal protein consuming individuals than the vegetable protein 
consumers (Robertson et a!., 1979b). In addition, flesh protein increases uric acid 
excretion due to additional purine nitrogen (Hesse et aI., 1993). Moreover, vegeterian 
food lowers the risk of urolithiasis by increasing urinary pH and citric acid excretion 
and decreasing urinary calcium excretion (Robertson et a!., 1979b; Hesse et a!., 1993). 
Goldfarb (1994) has reported that the occurrence of upper tract stone formation in 
northern and western India, where animal protein intake is higher, is four times greater 
than that in the southern and eastern regions of India 
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1.4.4. Salts 
Salts containing sodium and magnesium affect CaOx stone formation (Sakhaee et al., 
1993). High sodium intake contributes to hypercalciuria in patients with CaOx stones 
(Timio et al., 2003). An increase in urinary calcium and a decrease in urinary citrate are 
the lithogenic consequences of excessive intake of dietary sodium chloride (Sakhaee 
et aI., 1993; Hesse et al., 1993; Hess et al., 1999; Timio et aI., 2003). On the other hand 
mineral water containing calcium and magnesium reduces the risk of urolithiasis 
(Rodgers, 1997). The former acts by binding oxalate in the gut thereby reducing its 
availability for absorption and the latter acts in a similar way to form a more soluble 
salt with oxalate. Higher intake of dietary potassium reduces the risk of stone disease 
(Curhan et aI., 1996). Raised excretion of nonreadily resorbable inorganic sulphate is 
reported to escalate the disease (Giannini et aI., 1999). 
lA.5. Fluid intake 
Greater fluid intake reduces the risk of kidney stones (Curhan et al., 1996; Borghi 
et aI., 1999). However, choice of drinks is crucial as its mineral content plays an 
important role. For example, fluids like coffee, black tea, cola and too much alcohol 
increase the risk (Hesse et al., 1993; Rodgers, 1999). Sufficient consumption of herbal 
tea, mineral water, beer, and wine decreases the risk of kidney stones, whereas high 
intake of apple and grape fruit juice increases the risk (Hesse et al., 1993; Curhan et al., 
1996; Rodgers, 1999). Mineral water high in calcium and bicarbonate is the ideal 
beverage to dilute urine (Vahlensieck, 1986; Hesse et al., 1993). Increased fluid intake 
reduces the risk of urolithiasis by decreasing the concentrations of calcium and oxalate 
in urine (Goldfarb, 1994). Sufficient intake of tap water is recommended by 
Vahlensieck (1986). Although urinary stone formation is not very much associated with 
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hardness of water, the high magnesium content of hard water makes it preferable to soft 
water because magnesium inhibits stone fonnation (Rodgers and Spector, 1981). 
1.5. Mechanism of Stone Formation 
The mechanism of stone fonnation involves three processes, i.e. nucleation, growth and 
aggregation (Hess and Kok, 1996). 
1.5.1. Nucleation 
Nucleation refers to the proeess in which crystals are precipitated from a supersaturated 
solution. Nucleation of CaOx can take place either in the presence or absence of a 
substrate. A perfectly clear aqueous solution of CaOx remains stable over a wide range 
of supersaturation, called the zone of metastable supersaturation which goes up to RS 
values of 80 to 100 (figure 1, page 9) without nucleation of any crystals (Hess and Kok, 
1996). But urine does not usually reach the supersaturation necessary for nucleation 
without a substrate and this suggests that crystal nucleation in vivo requires such a 
substance (Kok, 1997). Foreign surfaces such as cell debris, epithelial membranes, 
some urinary macromoleculaes like self-polymesised Tamm-Horsfall glycoprotein and 
other crystal species present in the urine can induce nucleation of CaOx (Khan et al., 
1990; Khan et al., 1993; Hess and Kok, 1996). Thus it would appear that many surfaces 
in the urinary tract (including urinary macromolecules and epithelial linings) could act 
as nucleators of CaOx nucleation. 
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Homogeneous and heterogeneous nucleations 
Homogeneous nucleation is a process by which nucleation takes place spontaneously. 
As it is evident from figure 1 (page 9), this process takes place just beyond the upper 
limit of the interval of the metastability, a level where the solution becomes unstable, 
also called the level of formation product (FP) (Worcester, 1996). In the case of 
heterogeneous nucleation, crystals are precipitated on the surface of other substances: 
secondary nucleation (FP' in figure 1) or epitaxy (FP* in figure 1) (Worcester, 1996; 
Hess and Kok, 1996). Some urinary macromolecules are heterogeneous nucleators of 
stone formation: in their presence precipitation takes place at lower RS value (FP* in 
figure 1) (Sohnel and Grases, 1995). 
CaOx stones generally incorporate very small amounts of other crystalline particles 
(Geider et al. , 1996). Sohnel and Grases (1995) suggested that these crystalline 
particles can serve as nucleators of CaOx crystallization. Hydroxyapatite, calcium 
carbonate, brushite and uric acid satisfy this condition and they enable the 
supersaturated urine to crystallize CaOx (Geider et aI., 1996). The typical nucleation in 
stone formation is therefore heterogeneous nucleation because urine usually is not 
concentrated enough for homogeneous nucleation to occur (Finlayson et aI., 1984). 
1.5.2. Growth 
The process by which new crystal components are incorporated into the nucleus of 
previously fonned crystals is called crystal growth CHess and Kok, 1996). CaOx 
crystals in human urine are mostly small enough to be flushed out harmlessly. The 
normal transit time through the kidney is not long enough for crystals to grow to the 
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size range of the tubule which would culminate in them being trapped. Growth is 
therefore not regarded as a key formation in urolithiasis (Kok and Khan, 1994). 
1.5.3. Aggregation 
Aggregation is a process by which several particles in solution adhere together to form 
a large particle (Hess and Kok, 1996). Electrostatic attraction, van der Waals forces, 
liquid bridge, capillarity, viscous binder, solid bridge and shear force are the basic 
mechanisms by which aggregation takes place. The roles of liquid bridge and 
capillarity are not significant for the particles are totally immersed in urine. Because of 
the zeta potential (the repulsive electrostatic surface charge) of the immersed particles, 
the electrostatic forces are repulsive and work against aggregation of crystalline 
particles (Finlayson, 1978; Hess and Kok, 1996). Adsorbed proteins can act as viscous 
binders to help aggregation or can establish surfaces with increased negative charges 
leading to disaggregation (Scurr and Robertson, 1986; Christmass et al., 2002). 
Measurement of zeta potential helps the study of mechanism of urinary inhibitors. This 
measurement is especially helpful in assessment of inhibition of CaOx by inhibitors. 
Solid bridges can stabilize aggregation only after other adhesive forces enable the 
particles to be placed next to each other (Finlayson, 1978). When interparticle distances 
are very small, van der Waals forces exert their attractive force and help aggregation. 
The shear forces exerted by the turbulence in the crystal suspension or by solvent 
currents in tubular fluids may work in the favour of, or against aggregation. 
Healthy subjects can be distinguished from stone-formers by smaller degrees of 
aggregation. It is well known that crystalluria is common for normal and stone forming 
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subjects. However, urine from stone-formers contains more aggregated particles (Kok 
and Khan, 1994). 
1.6. Theories of stone formation 
There are three theories governing stone formation: (i) the matrix theory, (ii) the fixed 
particle theory and (iii) the inhibition/promotion theory. 
1.6.1. Tile matri~ tlleory 
The matrix theory of stone formation argues that precipitation of the stone-forming 
salts is promoted by crystallization-promoting macromolecules in urine by providing a 
specific ground substance (Robertson and Nordin, 1982; Ryall and Stapleton, 1995). 
These crystallization-promoting substances act as heterogeneous nucleators and enable 
precipitation to occur at lower urinary saturation (Ryall and Stapleton, 1995). 
According to this theory the heterogeneous nucleators, besides causing the crystals to 
nucleate and grow, act as a framework for the deposition of stone salts (Robertson and 
Nordin, 1982). Heterogeneous nucleating macromolecules remain trapped in the stone 
architecture and become part of the final stone structure. However, a molecule that has 
become part of the stone does not necessarily mean it had played a role of a nucleator 
or an inhibitor, as some may get trapped without affecting the crystallization process at 
all (Ryall and Stapleton, 1995). 
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1.6.2. TheflXed particle theory 
According to this theory, a stone is mainly formed under conditions where particles are 
retained by adhesion to cells or disturbed urinary flow (Finlayson et al., 1984). This 
theory implies that urinary crystals are endocytosed by the cells of the tubular surfaces 
to which they have adhered. Subepithelial calcified lesion can then be produced by 
subsequent migration of the endocytosed crystals. Upon losing its epithelial covering 
and coming into contact with urine at the level of supersaturation (SS), this lesion may 
act as nidus for the stone to further grow (figure 2) (Hess et af., 2001). 
Particle retention 
In this theory, particle retention is the determining process for stone formation because 
only retained crystals have a sufficiently long residence time to grow into full-size 
stones (Edyvane et al., 1987; Hess and Kok, 1996). Evidence exists that in calcium 
stone forming patients, patches of subepithelial papillary calcification (Randall's 
plaques) occur in the kidney of stone-formers to a higher degree than in nonstone-
formers (Randall, 1940; Bullock et at., 1998; Hess et at., 2001). Solutes are believed to 
crystallize on these nidi to form microcalculi that then slough off into urine collecting 
system to form the nuclei of large stones (figure 2). Formation of papillary calculi is 
believed to be a consequence of some alteration of the epithelium covering the renal 
papilla (ranging from a reduction in the protective GAGs to papillary necrosis). This 
facilitates an increase in calcium concentration of the tissue and depending on duration 
and levels of crystallization effectors, the initial development of attached particles of 
insoluble calcium salts may take place. (Bullock et al., 1998; Grases et at., 1998). 
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Finlayson et al. (1984) reported that CaOx crystals become retained by adhering to the 
sticky glycocalyx of renal tubular cell membranes. Other reports from Riese et al. 
(1992) have also shown that CaOx crystals adhere to renal papillary collecting tubule 
cells from rats. It has been suggested that increased gro\\l1h and aggregation of crystals 
retained as a result of the stickiness of tubular epithelia or as a consequence of 
epithelial injury are the main events that favour the process of partiele retention 
(Finlayson et aI., 1984; :Hess and Kok, 1996). 
Aggregate 
Crystal --110> retention 
aggregation (Tubular ~ 
/" lumen) ~ 
Urinary --+- Crystal --+-Crystal I 
SS nucleation growth 
\/ 
Crystal ---+- Crystal endocy· 
attachment tosis & migration 
{Tubular cell (Papillarv surface) 
surface) ~ 
Crystal 
endocytosis 
KIDNEY STONE 
FORMATION 
/ 
---+- Crystal exposure 
to pelvic urine 
(Randall's plaque) 
.. Intracellular cry· I 
stal dissolution 
Figure 2. Process of particle retention [Hess et al., 2001] 
1.6.3. The inhibition/promotion theory 
Inhibitors are urinary substances that retard one or more of the three processes of stone 
formation. Promo tors are substances that enhance stone formation by either increasing 
the urinary supersaturation or by providing foreign surfaces for heterogeneous 
nucleation (Hess and Kok, 1996). According to this theory, stone·formers lack or are 
deficient in inhibitors of crystallization (Robertson and Nordin, 1982). Urinary 
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substances are either promoters or inhibitors of the formation of kidney stones. They 
affect stone formation by enhancing or retarding one or more of the three major 
processes of crystallization described in section 1.5. Some urinary components may 
have both effects. Examples of urinary promoters and inhibitors are described in the 
following paragraphs. 
1.6.3.1. Promotors 
Almost all urinary CaOx crystals contain proteins within them. This may be evidence 
that the proteins act as promoters of stone formation (Doyle et ai., 1995). Proteins like 
osteopontin (OP), Tamm-Horsfall mucoprotein (THM) and nephrocalcin (NC) may 
either promote or inhibit aggregation (Ryall and Stapleton, 1995). Both OP and NC 
promote aggregation at pH 5.7 (Christmas et al., 2002) and at sufficiently low 
concentration (Ryall and Stapleton, 1995). Contradictory effects of THM are reported. 
Rose and Sulaiman (1982) reported THM to enhance CaOx precipitation in 
concentrated urine. On the other hand studies by Kitamura and Pak (1982) reported 
THM to be an inhibitor of CaOx nucleation and growth. Recent reports (Baumann, 
1998; Dussol and Berland; Craig el al., 2001) Suggest that under normal conditions, 
THM inhibits CaOx nucleation and growth but it promotes aggregation by presenting a 
preformed surface for crystallization when polymerized. Polymerization of THM is 
favoured by high concentration of THM itself, high urinary calcium and low pH 
conditions (Baumann, 1998; Dussol and Berland, 1998). Some studies have shown that 
OP can stimulate deposition of CaOx crystals on Madin-Darby canine kidney cells 
(Yamate et al. 1998, Yamate et al. 1999). It has recently been reported by Konya et al. 
(2003) that OP attached to collagen granule surfaces, may promote CaOx crystal 
deposition. 
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1.6.3.2. Inhibitors 
There are three mechanisms by which inhibition takes place: binding of calcium and 
oxalate ions by chelating agents, steric hindrance and blocking of grow1h sites (Ryall, 
1997; Christmas et aI., 2002). Some inhibitors retard nucleation by binding either 
calcium or oxalate (Ryall, 1997). This results in lowering the supersaturation of CaOx 
and hence the probability of precipitation is reduced (Grases et al., 1989a). Other 
inhibitors retard both growth and aggregation by binding to the crystal surface. Few 
other inhibitors retard grow1h and aggregation by steric hindrance (Christmas et ai., 
2002). Inhibitors can be classified as micromolecular (i.e., low molecular weight) or 
macromolecular (i.e., high molecular weight) inhibitors. 
Micromolecular inhibitors 
Low molecular weight or micromolecular inhibitors include magnesium, citrate and 
pyrophosphate. 
A1agnesiun 
Magnesium is shown by many studies to be effective in reducing CaOx crystallization 
both in vivo and in vitro (Li et al., 1985; Kohri et al., 1988). It reduces the risk of stone 
formation by complexing oxalate to form magnesium oxalate, a salt more soluble than 
CaOx (Hallson et aI., 1982). Thus, magnesium acts as an inhibitor of CaOx 
crystallization in its capacity as a binder of oxalate (Ryall, 1997). The work of Li e/ al. 
(1985) concludes that though they may have some gastrointestinal side effects, 
magnesium compounds are recommended treatments for idiopathic stone patients. Berg 
et at. (1986) reported lower urinary magnesium excretion in stone-fomlers compared 
with the normal subjects. A recent study by Siener and Hesse (1995) reported the 
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influence of magnesium-rich ovo-Iacto-vegeterian diet on urinary magnesium excretion 
and urinary concentration to be less than expected. 
Citrate 
Citrate inhibits nucleation, growth and aggregation by either complexing calcium or 
binding the crystal surface (Hallson et ai., 1982; Ryall ef al., 1985; Allie and Rodgers, 
2003). It complexes calcium thereby reducing the supersaturation of urine with respect 
to CaOx and consequently inhibits nucleation of CaOx crystals. It also inhibits both 
crystal growth and aggregation by binding the crystal surface (Ryall, 1997). Citrate can 
also counteract the heterogeneous growth of CaOx crystals on the surface of calcium 
phosphate crystals (Tiselius et al., 1993). CaOx stone-formers have lower urinary 
citrate excretion (hypocitraturia) compared to normal subjects (Grases et ai., 1989b; 
Tiselius et al., 1993). The inhibitory effect of citrate is reported to be less effective in 
hypercalciuric patients than those individuals with lower urinary calcium excretion 
(Grases et al., 1989b). As a consequence of the crucial role that citrate plays on CaOx 
crystallization, citrate supplementation has been a good therapy for CaOx stone disease 
(Tiselius et aI., 1993; Ryall, 1997). Among the common citrate supplements that have 
been used for stone disease treatment and found to be efficient are: potassium citrate 
(Pak and Fuller, 1986; Abdulhadi et aI., 1993), sodium potassium citrate (Schwille 
eta!., 1987; Berg eta!., 1990), calcium citrate (Levine etal., 1994; Sakhaee eta!., 
1994), calcium sodium citrate (Schwille et aI., 1997; Hermann et al., 1999), potassium 
magnesium citrate (Sakhaee et a!., 1983; Pak et aI., 1992) and sodium citrate 
bicarbonate (Allie and Rodgers, 2003; Bosch et aI., 2003). 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Pyrophosphate 
Pyrophosphate inhibits nucleation, growth, and a combination of growth and 
aggregation from an inorganic solution (Ryall, 1997). The inhibitory activity of 
phyrophosphate is attributed to its capacity to irreversibly bind to CaOx crystal surfaces 
(Ryall, 1997). Shirane and Kagawa (1993) reported that pyrophosphate binds COM in 
preference to COD and that it binds calcium in the solid phase rather than in the 
solution phase. A study by Gardner (1978) reported that at physiological concentration 
of pyrophosphate, fonnation of COM can be retarded or prevented while the growth of 
COD and COT are not affected. It also reduces the deposition of CaOx from undiluted 
urine (Ryall, 1997). But its contribution to the inhibitory activity of diluted urine is 
small (Ryall et al., 1981). Conte et af. (1989) reported reduced inhibitory effect of 
pyrophosphate from stone-fonners to be due to lower transfonnation of orthophosphate 
into pyrophosphate. 
Macromolecular Inhibitors 
Macromolecules, collectively called orgamc matrix, compnse only a small portion 
(2-3%) of the stone's weight, but are found spread throughout the entire stone structure. 
Reports from Borghi et al. (1995) showed a significant increase in oxalate tolerance 
parameters when macromolecules are removed by ultrafiltration from urine of CaOx 
stone-formers. On the contrary, no significant change was observed when urine from 
controls was ultrafiltered. This shows that ultrafiltration removed the difference 
between stone-fonners and controls. From this observation it can be suggested that 
urinary macromolecules play a detem1ining role in CaOx stone fom1ation. These 
comprise mainly two classes of compounds, namely GAGs and proteins (Doyle et aI., 
1995; Ryall, 1997). 
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Glycosaminoglycans (GAG) 
Urinary GAGs are polyanionic polysaccharides and are metabolic turnovers of those 
found in the tissues as proteoglycans (Shum and Gohel, 1993). Heparan sulphate (HS), 
chondrotin sulphate (CS) and hyaluronic acid (HA) are the most common urinary GAG 
molecules (Shum and Gohel, 1993). HS and HA are the only GAGs that have been 
shown to be present in kidney stones (Christmas et ai., 2002). CS, however, although it 
makes more than half of the GAGs in the urine it is not found in stones (Ryall, 1997). 
This may be due to the fact that CS has weak interaction with the surface of the CaOx 
crystals and therefore no inclusion. 
HS inhibits aggregation in urine and the inhibitory activity of HS from normal controls 
is higher than that from stone-formers. It also has higher inhibitory activity than CS 
from both normal subjects and stone-formers (Shum and Gohel, 1993). The same group 
suggested that the presence of HS in some stones may prove its effect as heterogeneous 
nucleator. Iwata and co-workers (1994) also compared the inhibitory activities of the 
urinary and commercial GAGs (specifically HS and CS). They concluded that urinary 
and commercial GAGs have no significant differences and that HS is a stronger 
inhibitor compared to CS. 
CS is reported to be a potent inhibitor of CaOx crystal growth and aggregation from 
inorganic media (Ryall et aI., 1981). CS is unique in promoting heterogeneous 
nucleation of COM on hydroxyapatite but inhibits growth (Beshensky et al., 2000). In 
contrast to this, other works showed its contribution in CaOx crystallization in vivo to 
be insignificant (Ryall et aI., 1991; Ryall, 1997). 
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llA is suggested to promote crystallization in early stages in stone-formers (Gohel, 
et aI., 2000). Some genetic disorders like bladder cancer and Graves' disease bring 
about a change in the urinary excretion of HA (Gohel et aI., 2000). Its presence in urine 
in trace amounts and close structural similarity with CS makes the isolation and study 
of HA difficult (Zebrower et al., 1986). 
Proteins 
Human urine contains many proteins but only a few of these proteins have thus far been 
identified as playing a role in CaOx stone formation (Ryall, 1996). Urinary 
prothrombin fragment 1 (UPTF 1), Tamm-Horsfall mucoprotein (THM), osteopontin 
(OP), nephrocalcin (NC) and human serum albumin (HSA) will be discussed briefly in 
this section. 
Urinary prothrombin fragment I (UPTF 1) 
UPTFI is unique from other protein inhibitors in that it inhibits both growth and 
aggregation from both aqueous inorganic solution and human urine whereas most of the 
other inhibitors inhibit aggregation strongly and grow1h only weakly from both 
solutions (Doyle et ai., 1995). Compared to healthy controls, stone-formers have higher 
concentration of UPTFI probably because its level rises in response to lithogenic 
conditions (Ryall, 1997). Reports irom Grover et aI., (1998) showed that UPTFI is a 
potent inhibitor of CaOx aggregation. Despite its low concentration in human urine, 
CaOx stones usually contain large quantities of UPTFI probably due to the fact that 
UPTFI has a better effect of binding to CaOx crystal surface. Recent studies by 
Webber et al. (2003) reported greater amount of UPTFI in crystals from the urine of 
black South Africans compared to that from the white citizens. These workers have 
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speculated that this could be a contributory factor to explain the rarity of stones in the 
black population and serves to illustrate the role of this protein as a powerful inhibitor. 
Tamm-Horsfall mucoprotein (THAI) 
Unlike most of the other macromolecular inhibitors, THM acts by steric hindrance 
rather than binding to the crystal surface (Ryall et aI., 1991; Doyle et aI., 1995). Its 
physical state in urine is affected by pH, ionic strength and its own concentration (Ryall 
et al., 1991). Under normal conditions, its inhibitory effect on crystal nucleation and 
gro\\1h is not significant but under conditions like low pH and high ionic strength 
(Hess, 1994) it promotes nucleation. It is not found in CaOx crystals precipitated from 
urine and its urinary concentration does not differ between stone-formers and healthy 
subjects (Ryall, 1997). Self-polymerization of THM reduces its inhibitory effect on 
CaOx aggregation (Hess et aI., 1989). Although low pH and high ionic strength 
conditions reduce its activity, THM is a potent inhibitor of crystal aggregation (Hess 
et aI., 1989; Hess, 1994; Worcester, 1996). In vitro experiment on black versus white 
South Africans by Craig et al. (2001) suggests that THM inhibits CaOx nucleation and 
aggregation and that the inhibitory activity of the protein derived from blacks has 
greater inhibitory activity than that obtained from the white subjects. 
Osteopontin (OP) 
It was reported by Nishio et al. (1999) that OP is a strong inhibitor of growth of CaOx 
at physiological urinary concentrations but promotes CaOx formation at lower 
concentrations. It stereospecifically binds to the surface of the crystals thereby retarding 
gro\v1h (Ryall, 1997). OP at physiological concentrations can inhibit homogeneous 
nucleation, growth and aggregation of CaOx crystals in supersaturated solutions in vitro 
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(Worcester, 1996). The effect of OP in urine has not been studied but despite its lower 
concentration in urine compared to nephrocalcin, its presence in stones in quantities 
greater than nephrocalcin might suggest that it binds to CaOx crystals more strongly 
and may consequently be a more potent inhibitor (Ryall and Stapleton, 1995; Ryall, 
1997; Grover et al., 1998). Wesson et al. (2003) showed that OP inhibits crystal 
formation and retention in vivo. It inhibits stone formation by favouring COD at the 
expense of the crystal with high affinity to papillary cells, COM, and hence reduces 
retention. Recent evidence shows that OP is found in lower concentration in stone-
formers than in healthy subjects (Nishio et aI., 2001). 
Nephrocalcin (NC) 
NC exists as a monomer, dimer, trimer or tetramer. The monomer has molecular 
weight approximately 14-15 kDa (Ryall and Stapleton, 1995). In vitro studies by 
Worcester (1996) suggest that at concentrations similar to those found in urine, NC can 
inhibit nucleation, growth and aggregation of CaOx crystals in supersaturated CaOx 
solutions. NC may also reduce cell-crystal adhesion (Worcester, 1996). NC is reported 
to contain between two and three y-carboxyglutamic acids (Gla) per molecule. The 
inhibitory activity of NC is reduced when it is deficient in Gla (Grover et aI., 1998). 
NC from renal stones and urine of stone-fonners lacks Gla (Hess et aI., 1989). 
Human serum albumin (HSA) 
Studies by Ryall et a!. (1991) showed that HSA, although abundant in human urine is 
found in trace amounts (if any) in CaOx kidney stones. These workers suggest that 
HSA inhibits both growth and aggregation of CaOx crystals in aqueous inorganic 
medium but that its eflect on CaOx crystallization in undilutued human urine is not 
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significant. The work of Cerini and associates (1999) suggested that HSA inhibits 
COM aggregation by favouring the fonnation of COD crystals. This is because COD 
crystals have lower af1inity to renal papillary cell membranes (because they have lower 
negative charges compared to COM crystal). Mensah et al. (2003) demonstrated that 
HSA from black South Africans carries greater negative charges and shows greater 
inhibition of COM crystal aggregation than that derived from white subjects. 
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1.7. Conclusion 
CaOx is the most common component of urinary calculi (Robertson and Peacock, 
1980; Takasaki 1986; Edyvane et al., 1987; Grases et al., 1998). The conditions under 
which it crystallizes in the urine, either via the matrix theory (Ryall and Stapleton, 
1995), or the fixed particle theory (Kok & Khan, 1994) or by invoking the activity of 
inhibitors and promoters (Ryall, 1997) continues to be the subject of research in many 
laboratories. Many attempts have been made to control the mechanisms of 
crystallization in urine (and hence provide insights into how kidney stone disease might 
be managed). Conservative methods like dietary intervention or alteration of urinary 
composition via administration of various preparations have had some measure of 
success. However, none of them have provided a complete understanding of the 
process. More basic rcsearch is required on controlling and directing crystallization 
processes in urine. One such area is molecular imprinting which has been used in some 
industrial and biological processes (WulfT, 1995) but has not been explored in the 
context of urolithiasis. Molecular imprinting presents an innovative approach to 
investigating CaOx crystallization processes. The next chapter provides background 
and motivation for pursuing the concept in the area of kidney stone formation. 
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CHAPTER TWO - MOLECULAR IMPRINTING 
2.1. The concept of molecular imprinting 
Molecular recognition IS the basis for many biological processes that involve 
interactions between natural biomolecules such as enzymes, antibodies, nucleic acids 
and cellular receptors (Trotta et a!., 2002). Biological recognition elements have been 
interesting because of their extreme sensitivities and specificities. The discovery of the 
more stable recognition system obtained by molecular imprinting of polymers has made 
progress in solving the problem of durability and operational stability that the 
biological recognition elements lack (Kriz et al., 1997). Molecular imprinting is a 
technique by which molecular recognition is produced by binding and crosslinking a 
polymerisable monomer around a template molecule (Spivac and Shea, 1999). A cavity 
with functional groups in a certain orientation and capable of chemical interaction is 
left in the polymer after removal of the template molecule (Rachkov and Minoura, 
2001; Strikovsky eta!., 2003). For the imprinted polymer to be highly selective, the 
cavity is required to have a shape that exactly matches that of the template and the 
binding sites must have a definite spatial arrangement (Wulff, 1995). The molecular 
imprinting technology was first developed by Wulff and Mosbach in the 1970s for the 
purpose of synthesis of artificial enzyme mimics or chromatographic separations 
(Hirantani and Alvarez-Lorenzo, 2002). The synthesis is usually performed by 
copolymerization of functional and cross-linking monomers in the presence of a 
molecular template and additional solvents that induce porosity in the molecularly 
imprinted polymer (or porogens). A schematic representation of the process of 
molecular imprinting is shown in figure 3. 
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a) b) 
Figure 3. Schematic representation of the imprinting of specific cavities in a 
crosslinked polymer by a template (T) with three different binding groups 
showing (a) Pre-arrangement of functional groups of the monomer to 
appropriate sites in the template; (b) Pre-polymer complex; (c) Highly 
crosslinked polymer with well arranged chains; and (d) well-defined cavity left 
after template removal [Wulff, 1995]. 
The functional monomers have to interact with the template molecules by either 
covalent or noncovalent bonding, leading to two basic approaches to molecular 
imprinting: the covalent approach and the noncovalent approach (Ram strom, 1996). 
Both approaches use a high percentage of crosslinking that helps in making the 
polymer rigid enough just to maintain its three-dimensional structure after template 
removal and to remain insoluble. Both approaches result in a common recognition 
mechanism. They only differ in their prepolymerization interactions. 
In the covalent approach which was originally proposed by Wulff (figure 4), the 
template molecule and the monomer are linked by reversible covalent bonds prior to 
polymerization (Ramstrom, 1996). In this case derivatization of the template molecule 
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with the monomer is required before polymerization. The template is then removed by 
cleavage of the covalent bond and recognition sites complementary in shape and 
functionality to the template molecule are left in the polymer. The structure of the 
template molecule determines which interactions are most favourable in the specific 
case. 
Pre-polymer complex formed by covalent bond 
between the template (in this case, phenyl-a-D-
mannopyranoside) and two molecules of the 
functional monomer (4- vinylphenylboronic acid) 
Removal of the template (T) by bond cleavage to give a well-defined 
cavity and addition of the template to reoccupy the cavity. 
Figure 4. Schematic representation of a covalent bond interaction between the 
template and functional monomer [Wulff, 1995]. 
In the noncovalent approach which was initially proposed by Mosbach (figure 5), weak 
intermolecular interactions are involved in the prearrangement between the template 
molecule and the functional monomer (Ramstrom, 1996). Ionic or hydrophobic 
interactions, hydrogen bonding and metal coordination are the interactions commonly 
utilized in this approach. A self-assembled complex is spontaneously formed between 
the functional monomer and the template molecule. The polymerization reaction takes 
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place in the presence of a cross linker, an initiator and a suitable solvent. A polymer 
matrix with specific recognition elements (cavities) then results after the washing out of 
the template molecule (Byrne et aI., 2002). Selectivity comes about because of the 
shape of the cavity and the arrangement of functional groups within it (Wulff, 1995). 
H(5'N o~"O 
7"1 
~ 1 
Figure 5. Schematic representation of noncovalent interaction. Hydrogen 
bonding and electrostatic interaction are involved here. Acrylic acid functional 
monomer (shown in figure 6, page 35) and L-phenylalanine anilide template (1) 
are used in this example [Wulff, 1995]. 
Sometimes polymers with better selectivities than both of the above mentioned 
strategies can be obtained by using the combination of covalent interactions and 
noncovalent interactions (Wulff, 1995). 
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2.2. Structure of the polymer matrix 
The structure of the polymer matrix is very important in the imprinting process (Wulff, 
1995). Systematic variation of parameters like the ratio of crosslinking agent, type and 
concentration of functional monomer, solvent and template molecules is usually 
required in order to optimize the polymer structure (Hentze and Antonietti, 2001). The 
following are some of the properties that the polymer needs to have. 
a) Flexibility. High flexibility makes the equilibration with the substrate to be 
embedded rapidly and also helps the cavities to be accessible. But too high 
flexibility leads to a loss of structural definition and selectivity (Wulff, 1995; 
Hentze and Antonietti, 2001). 
b) Rigidity. Since recognition requires three-dimensional orientation, control of the 
polymer chain relaxation is necessary. High ratio of crosslinking agent to 
functional monomers helps the polymer structure to be stiff and hence enables 
the cavities to retain their shape after removal of the template, resulting in high 
selectivity. Too rigid structure, however, leads to lower accessibility of the 
cavities (Byrne et aI., 2002; Wulff, 1995). 
c) Stability. Mechanical, thermal and chemical stability of polymer enables it to be 
used for many applications. For example, mechanical stability is important if 
the imprinted polymer is meant for use in an HPLC column at high pressure or 
as a catalyst in a stirred reactor. Thennal stability enables it to tolerate high 
temperatures at which the kinetics are more favourable (Wulff 1995). Chemical 
stability helps it to tolerate a wide range of pH and organic solvents. 
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From the first two properties discussed above, it can be concluded that a compromise 
must be found between a stiff structure to give high selectivity and flexibility which is 
necessary for good accessibility of the cavities (Wulff, 1995). 
2.3. Function of the binding groups 
2.3.1. Functional monomer 
The choice of the functional monomer is a determining factor in preparing an imprinted 
polymer for a particular purpose. The functional monomer has to be one with a binding 
group that forms a strong bond with the template in order to have a definite orientation 
of the binding groups on the polymer chains when they are crosslinked (Sellergren, 
2000). There must also be a complete removal of the template after polymerization is 
complete. Lastly, the interaction between the binding groups and the template molecule 
has to be as labile and reversible as possible. This property is especially useful when 
the purpose of the imprinting is for chromatographic separations or catalysis. Although 
the binding groups in the noncovalent approach are not fixed in space during 
polymerization as precisely as that of covalent interactions and a considerable excess of 
binding groups is required, noncovalent interactions have the advantages of easily 
removmg the templates and rapidly reversible interactions with substrates (Wulff, 
1995). 
Depending on the type and spatial arrangement of the interacting groups, polymers vary 
in their effect on crystal morphology. For instance, carboxyl or phosphoryl side chains 
are more effective than sulphonyl side chains and neutral and amino acid side chains 
have no effect on CaOx crystallization (Wesson el ai., 2000). These workers have also 
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suggested that a morphology change within a crystal structure results from a face-
specific inhibition of crystallization. The most commonly used functional monomers 
contain carboxylic acid, sulphonic acid, or heteroaromatic base functional groups. 
Methacrylic acid for example is very commonly used because the carboxylic acid group 
serves as a proton donor as well as acceptor in the hydrogen bonds formed (Sellergren, 
2000). Some commonly used functional monomers are shown in figure 6. 
"'COOH 
acrylic acid 
~ v..COOH 
4-vinylbenzoic acid 
2-vinylpyridine 
~COOH 
methacrylic acid 
(COOH 
.ACOOH 
itaconic acid 
4-vinylpyridine 
~N"""""caaH ~ "'-caOH 
4-vinyl benzyl-iminodiacetic acid 
CF3 ~COOH 
trifluoro-methacrylic acid 
I-vinylimidazoJe 
~NH 
N:::::/ 
4(5)-vinyJimidazoJe 
2-acrylamido-2-methyl-
I-propane sui phonic acid 
Figure 6. Some examples of functional monomers used in self-assembly 
imprinting [Ramstrom, 1996]. 
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2.3.2. Templates and porogens 
The pore size and morphology of the imprinted polymer can be controlled by making a 
good choice of porogens and templates. The porogens and templates have to be present 
until the end of the formation of the polymer matrix and removed after the reaction. 
Generally, the imprinted cavities embed the template molecules in preference to any 
other substance. The template, the selected target substance used in the imprinting 
process, needs to be soluble in the solvent to be used and stablity under the operational 
conditions is required (Sellergren, 2000). It has to be also one that does not react with 
the free radicals used to initiate the polymerization. If a solvent with too low polarity is 
used, the interactions with the functional monomer will not be specific enough, while a 
too high polarity also causes low solubility of the monomer solution (Hentze and 
Antonietti, 2001). High polarity also leads to poorer recognition because it weakens the 
interaction forces formed between template molecules and functional monomers 
(Ramstrom, 1996). The solvent should also not interfere or compete with any of the 
intended noncovalent interactions employed during template-monomer complex 
formation as otherwise a less effective recognition will result (Byrne et al., 2002). 
2.3.3. Crosslin king agent 
The type and quantity of the cross-linking agent is crucial for high selectivity. Although 
it strongly influences the morphology of the polymer, the type of the porogen used has 
no significant effect on the selectivity of the cavities formed. Besides the cross-linking 
agent the porosity and the inner surface area play an important role in determining the 
accessibility of the cavities (Wulff: 1995). The inner diffusion of imprinted molecules 
toward the reactive sites, which are deeply formed in the polymer matrix makes the 
reaction kinetics slow (Toorisaka et aI., 2003). As it is shown in figure 7, polymers 
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crosslinked by 1,4-divinylbenzene (dvb) are less efficient for molecular separations 
because of the stiffness of the structure. But it must be noted that imprinted polymers, 
especially those used for crystal imprinting (D'Souza et al., 1999), need to be rigid. In 
this last case, dvb is preferred to ethylene dimethacrylate and tetramethylene 
dimethacrylate which are both more selective than dvb but are too flexible to be used 
for crystal nucleating polymers. Some examples of cross-linking agents are shown in 
figure 8. 
4.00 
3.50 
t 
3.00 
Ko 
KL 
2.50 
2.00 
1.50 
1.00 
10 20 30 40 
• 
a) • 
. / 
~ 
50 60 70 80 90 100 
X [%] ---+ 
Figure 7. Selectivity of polymers as a function of the type and mole % (X) of 
crosslinking agent. Separation factor, a = Ko/KL for the resolution of phenyl-D-
L-mannopyranoside in a batch process after removal of the template (T) from 
the pre-polymer complex 'a' (figure 4, page 31) polymerized with various 
proportions of the crosslinking agents a) ethylene dimethacrylate, 
b) tetramethylene dimethacrylate, and c) dvb [Wulff, 1995] 
Jy~Xo 
o 
ethylene dimethacrylate 
>-<~}-\ 
o 
tetramethylene dimethacrylate 
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4-divinylbenzene 
H 
'YN'l('l 0 
o v...N~ 
H 
N,l\"' -phenylene-bisacrylamide 
Jyo-v'oJy 
o 
ethylene glycol dimethacrylate 
H H 
'YN'-,/N'J(' 
o 0 
N,N'-methylene-bisacrylamide 
~N~NJv, 
H H 
2,6-bisacrylamidopyridine 
~~ ~~ 
o 
trimethylol propane 
trimethacrylate 
Figure 8. Some of the commonly used crosslinkers [Ramstrom, 1996]. 
2.3.4. Binding sites and substrate recognition 
Unless otherwise cited, this section is composed of ideas taken from the review article 
by Wulff (1995). If the purpose of imprinting is for catalytic activity as in this work, a 
definite arrangement of the functional groups is very important (Hentze and Antonietti, 
2001). 
A specific embedding of the template molecule into a cavity that exactly tits to its size 
and that has functional groups that correspond to its interacting sites is required. Most 
template molecules have two binding groups which is the ideal number to optimize 
selectivity and kinetics. Most of the time these binding groups are identical but they can 
produce nonidentical binding sites in the imprinted cavities (figure 9). There can occur 
a productive (figure 9c) or unproductive (figure 9b) one-point binding. The productive 
one-point binding upon further reaction leads to the desired two-point binding 
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(figure 9a). However, no second bond is possible in case of the unproductive one-point 
binding. This bond has to be broken in order for one of the two productive one-point 
bonds to be formed. Although it is formed more slowly, the correct two-point bond has 
the highest association constant. Imprints with three or more binding sites are 
inefficient as the number of possible unproductive complexes is large and formation of 
the productive complex is correspondingly slower. 
b) c) 
Figure 9. Schematic representation of two-point binding (a), unproductive one-
point binding (b), and a productive one-point binding (c) [Wulff, 1995]. 
2.3.5. Effect of swelling 
The volume of the polymers and especially of the cavities increases as a consequence 
of removal of the template. The extended cavities can then embed the template easily. 
Surprisingly, the cavities shrink to almost the original volume after the template is 
rebound. The higher the temperature the more selective is the imprinted polymer. This 
is partly due to the faster formation of the more selective two-point binding at raised 
temperatures. Besides, swelling makes the particularly highly selective cavities, those 
that are unaccessible at room temperature, accessible. On the other hand, sometimes, 
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relaxation of strain and swelling of the matrix after the removal of the template may 
cause the cavities to change their shape and make the embedding of the template 
impossible (Wulff, 1995). Swelling effects are more pronounced in aromatic solvents 
than in aliphatic organic solvents. The strong interaction between the imprinted 
polymer and the aromatic solvent causes swelling, and hence deformed cavities and 
consequently relatively low selectivity (Toorisaka et al., 2003). 
2.4. Applications of molecular imprinting 
Molecularly imprinted polymers have been used in a wide range of applications that 
involve analysis and separation, as well as synthesis techniques. Antibody/antigen and 
receptor binding mimics (Shi et aI., 1999), selective catalysts (enzyme mimics) 
(Strikovski et al., 2003; Mercier et al., 2000; Lele et al., 1999), chromatography 
(Rachkov et al., 2000; Mathew-Kritz & Shea, 1996) and biosensors (Kriz et aI., 1997) 
are some of the promising areas where molecular imprinting is applied. This section 
will briefly discuss some of the above-mentioned applications and some other specific 
works reported on the application of molecularly imprinted polymers. 
2.4.1. Molecular(v imprinted polymers as artificial antibodies 
Molecularly imprinted polymers have a number of advantages over their natural 
counterparts such as enzymes and antibodies. They are equally or more potent, they 
work at lower concentrations and are less expensive. Kriz et al., (1997) have reported 
that molecularly imprinted polymers have recognition properties that tolerate acid, 
base, heat or organic phase treatment and this makes them suitable to be used as 
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chemical sensors. Molecular imprinting can be applied not only to low molecular 
weight targets but also to large molecules such as proteins (Sellergren, 2000). 
Shi et ai. (1999) imprinted three blood proteins; bovine albumin, serum 
immunoglobulin and fibrinogen to compare protein recognition by template-imprinted 
surfaces and non-template surfaces. A decrease in the nitrogen signal of electron 
spectroscopy for chemical analysis (ESCA) and the time-of-flight secondary ion mass 
spectrometry (TOF-SIMS) peaks which are indicative of protein fragments confirmed 
the removal of the imprinted proteins by a basic solution. They reported a better 
recognition of proteins by the protein imprints compared to the non-template polymers 
confirming the specificity of template recognition. Template recognition happens 
through a multistep adsorption, with the specificity resulting from shape selectivity and 
hydrogen bonding. Van der Waals forces also contribute to the specificity due to steric 
complementarity. From this it can be suggested that, like antibodies, molecularly 
imprinted polymers can be used in highly sensitive separation techniques like screening 
of proteins that are very similar to one another. 
2.4.2. Molecularly imprinted polymers for cllromatograpllic separations 
Ye and Mosbach (2001) prepared molecularly imprinted polymers with binding sites 
made up of uniform polymer microspheres. They used phase controlled precipitation 
polymerization methods in a dilute solution of functional monomer and crosslinker to 
prepare the imprinted polymer. 
The solvent used to prepare such micro spheres by a noncovalent approach should not 
interfere with the driving force of the polymer matrix formation, but it has to be 
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miscible with the monomer and initiator used and it should not dissolve the polymer 
formed. These molecularly imprinted polymer microspheres have been used for chiral 
separation. Ye & Mosbach have cited an example in which (-)-ephedrine was used as a 
template and the racemates, ephedrine and salbutamoL were separated by capillary 
electrophoresis. Migration of the analy1e towards the cathode and the molecularly 
imprinted polymer microspheres containing the bound enantiomer to the anode enabled 
the chiral separation. 
2.4.3. Catalytically active molecularly imprinted polymers 
Lele et al. (1999) synthesized a series of molecularly imprinted polymer mimics of 
chymotrypsin by grafting a CoCTI) coordinated monomer-template assembly containing 
dif1erent functional groups like hydroxyl, carboxyl and imidazole groups on to the 
surface of a microporous support. They used the Michaelis-Menten kinetics model to 
evaluate the hydrolytic activity of the mimics. This activity was observed to increase 
with an increase in nucleophilicity of the monomer used and a decrease in surface area 
of the imprinted polymer produced. Kunitake and Okahata (1976) have also tried to 
synthesize the same series of mimics comprising imidazole and carboxyl functions, 
however, Lele et al. suggested that this study lacked a specific mechanism of bringing 
the two functional groups next to each other and a mechanism for template recognition. 
Beach and Shea (1994) reported an effective catalytic acceleration by molecularly 
imprinted polymers using benzylmalonic acid template and N-(2-aminoethyl)-
methacrylamide monomer. This imprinted polymer was observed to position the 
polymerizable amines in a definite arrangement in the cavity. Compared to the reaction 
in solution (figure 10) and in the presence of control polymer (figure 11), this template 
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imprinted polymer showed accelerated catalysis of the dehydrotlourination of 4-fluoro-
4-(p-nitrophenyl)butan-2-one (fnb, 2) 
r:.l.HJl OaNJl] I ~ 
2 
.HF. I J OaNJl] ,-- ~ 
Figure 10. Dehydroflourination offnb [Beach and Shea, 1994] 
As it is shown in figure 11, hydrogen bonding interaction between polymer and 
substrate is involved in this reaction. The polarity of the reaction solvent is, therefore, 
important. Beach and Shea proved that the use of more polar solvents such as 
acetonitrile and ethanol slowed down the rate of the dehalogenation reaction of the 
imprinted polymer. 
is f)~ \ \ 
2 
Figure 11. Catalyst design for the dehydroflourination of fnb [Beach and Shea, 
1994)] 
This template was also observed to exhibit effective turnover, Michaelis-Menten 
kinetics and competitive inhibition of the dehydrotluorination reaction of fnb. 
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2.4.4. Imprinting of crystals for structure-directed nucleation 
Recently D'Souza et at. (1999) have reported the nucleation of calcite (calcium 
carbonate) crystals on the surface of a polymer imprinted with these crystals, 
demonstrating the utility of this approach in biomimetic mineralization. The polymer 
used was a co-polymer of 6-methacrylamidohexanoic acid (maaha) and dvb. After 
removal of calcite, this imprinted polymer was shown to be capable of nucleating 
calcite under conditions that would normaUy favor the growth of aragonite, another 
calcium carbonate polymorph, (figures 12 and 13). When they soaked 1.0 mg/ml of the 
calcite imprinted and washed polymer in an aqueous solution of (1.0 mM CaCh and 
0.8 mM NaC03), calcite crystals that are noticeably larger than those formed in the 
solution were observed. On the other hand, very few crystals were observed on the 
surface of the unimprinted (control) polymer soaked in the same solution (figure 12e). 
Figure 12. Nucleation of calcite at a polymer surface. Scanning electron 
micrographs showing: a) template calcite crystals, b) calcite imprinted polymer, 
c) calcite imprinted polymer after HCIICH30H wash, d) nucleation of calcite 
crystals on the surface of imprinted and washed polymer, and e) unimprinted 
(control) polymer soaked in supersaturated CaC03(aq) [D'Souza et al., 1999]. 
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Figure 13. Characterization of CaC03 crystal polymorphs. a) XRD patterns 
recorded using Cu Ka radiation showing calcite nucleation on the imprinted 
polymer b) FT-IR spectra showing evidence of CaC03 nucleation on the 
polymer surface [D'Souza et al., 1999]. 
The poor wettability of the polymer was modified by addition of 10% (v/v) acetonitrile 
which helped up to 50% of the sites to be occupied with crystals. They showed in a 
separate experiment that acetonitrile does not affect the crystallization of CaC03 
crystals. The same monomer imprinted with aragonite, however, did not direct the 
nucleation of aragonite crystals. Why only the calcite imprinted polymer led to an 
efficient nucleation whereas the aragonite imprinted polymer did not is not clear. The 
number of crystals on the surface of the control polymer and imprinted polymers whose 
carbonyl groups were blocked before nucleation was negligible, demonstrating that 
nucleation was specifically bought about by the imprint sites. 
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2.5. Conclusion 
It is well known that the concentration of calcium oxalate forming ions in urine is too 
small for spontaneous nucleation to occur. Nucleation of calcium oxalate crystals 
in vivo is thus believed to take place on the surface of a substrate (Nancollas et al., 
1991; Khan et aI., 1993). Urinary macromolecules which are mainly proteins and 
GAGs are the substances that are believed to act as substrates. Although several 
techniques have been used for studying the crystallization of calcium oxalate crystals in 
vitro, only a few have been able to crystallize CaOx below its metastable limit using 
some nucleation promoting surfaces (Khan et al., 1990; Khan et aI., 1993). Moreover, 
the anionic functionality (e.g., carboxylate) present in anionic molecules or 
macromolecules determine the morphology of crystals and hence affect crystal 
aggregation and adhesion of crystals to cells (Sheng et al., 2003). 
The work of D'Souza and co-workers has opened the gate to molecular imprinting that 
can be used to direct crystal nucleation. Molecular imprinting provides a novel 
technique that may be used to mimic the in vivo crystallization of calcium oxalate 
crystals from solutions at concentrations that do not allow spontaneous precipitation of 
calcium oxalate to take place. 
The work described in this thesis is aimed at utilizing molecular imprinting technology 
for crystallization of calcium oxalate crystals on the surface of a polymer imprinted 
with these crystals with a view to ultimately gaining a better insight into understanding 
the formation of human kidney stones. 
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CHAPTER THREE - OBJECTIVES 
This study was aimed at investigating the crystallization of calcium oxalate crystals via 
a new method, molecular imprinting. The following objectives were defined 
To prepare calcium oxalate monohydrate (COM) and calcium oxalate dihydrate 
(COD) crystals 
To prepare unimprinted (control) polymer and to imprint samples thereof with 
both CaOx hydrates. 
To test formation of CaOx crystals of both hydrates from metastable CaOx 
solutions in the presence and absence of the imprinted and unimprinted 
polymers. 
To repeat the above experiments usmg synthetic unne with varymg 
concentrations of magnesium and citrate. 
To investigate whether imprinted polymer of each hydrate is able to direct the 
formation of CaOx crystals under conditions which alternatively favour the 
formation of each hydrate itself. 
To measure metastable limit of human urine in the presence and absence of the 
control and imprinted polymers. 
To test human urine for the fornlation of CaOx crystals of both hydrates using 
the imprinted polymers. 
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CHAPTER FOUR - EXPERIMENTAL PROCEDURES 
4.1. Preparation of calcium oxalate template crystals 
4.1.1. Calcium oxalate monohydrate crystals 
Calcium oxalate monohydrate (COM) crystals were prepared by the method of Pak 
et aI., (1975) by simultaneously mixing equal volumes of O.OlO M CaCh and 0.010 M 
Na2C204 at a rate of 1 ml per minute using a peristaltic pump to give a final total 
volume of lOOO m!. The reaction mixture was stirred at 6 °c in a cold room for one 
week. The precipitate was then filtered, washed with distilled water and methanol and 
then dried for 1 hour at 95°C. A mass of 0.59 g of calcium oxalate was obtained, i.e. 
the percentage yield was 92 %. 
4.1.2. Calcium oxalate dihydrate crystals 
Calcium oxalate dihydrate (COD) was prepared according to the method of Brown 
et aI., (1989) with some modifications in the incubation temperature and final volume. 
A solution of volume 250 ml containing 1.398 g sodium citrate (0.01926 M), 1.423 g 
magnesium sulfate (0.0231 M) and 2.4025 g potassium chloride (0.l274 M) was 
prepared. To this was added 125 ml of 0.02508 M calcium chloride (prepared using 
CaCh.2H20) and the pH was adjusted to 6.5 by the addition of HCl. The solution was 
allowed to equilibrate at 26°C for 15 minutes. Thereafter, 125 ml of 0.0064 M NaOx 
was added with continuous stirring. The solution was incubated for a further 15 minutes 
at 26°C and then filtered through a 0.22 flm filter. Excess supernatant was poured off 
and the sample was suspended in methanol. The sample was centrifuged again and the 
excess methanol was removed. The crystals were dried at 37°C for 2 4 hours. 
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Prior to using the above protocol, difficulties were experienced in obtaining pure COD 
crystals using the final volume of 5 litres recommended by Brown et al. (1989). The 
latter protocol yielded pure COD crystals for the first few batches only but thereafter 
yielded a mixture of COD and COM with trace amounts of COT. However the method 
yielded pure COD reproducibly when the final volume was reduced to 500 ml, the 
samples were filtered instead of centrifuged and the incubation temperature was raised 
from 22 DC to 26 DC, as described above. 
Formation of pure COM and COD crystals was verified by X-ray powder diffraction 
(XRD), Fourier transform infrared spectroscopy (FTIR) and scanning electron 
microscopy (SEM). This will be discussed in detail in section 4.4. 
4.2. Urine and urine like solutions 
4.2.1. Saturated calcium oxalate solution 
A series of three calcium oxalate solutions within the metastable region (table 4.1) were 
prepared by mixing calcium chloride and NaOx solutions as follows: (I) 0.006 M 
calcium chloride (10 ml) and 0.006 M NaOx (10 ml) to give 0.003 M CaOx solution, 
(II) 0.010 M calcium chloride (10 ml) and 0.010 M NaOx (10 ml) to give 0.005 M 
CaOx solution and (UI) 0.012 M calcium chloride (10 ml) and 0.003 M NaOx solution 
(10 ml) to give a solution with a 4: 1 calcium-to-oxalate ratio. 
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Table 4.1. CaOx solutions prepared for crystallization experiments 
Solution I Solution II Solution III 
0.003 M CaOx 0.005 M CaOx 4:1 Ca:Ox solution 
Prepared by mixing Prepared by mixing I Prepared by mixing 
0.006 M CaCb with • 0.010 M CaCb with 0.012 M CaCb with 
0.006 M NaOx. 0.010 M NaOx. 0.003 M NaOx. 
4.2.2. Artificial urine 
Artificial urine was prepared by the method of Brown et aI., (1989) by sequentially 
dissolving the following components in water (final concentrations are given in 
brackets): 3.032 g NaCI (0.1055 M), 2.228 g NaH2P04.H20 (0.323 M), 0.472 g 
(0.01695 M) and 2.375 g KCI (0.0637 M); to this solution was added 0.422 g 
CaCb.2H20 (0.00575 M) and 0.021 g Na2C20 4 (0.000318 M). The pH was adjusted to 
6.5 by first adding 0.740 g NH4Cl (0.0276 M) followed by the required volume of 
concentrated NH40H. The solution was made up to 500 ml with distilled water in a 
volumetric flask and then filtered through a 0.22 11m filter before use. 
For the experiments m which magnesIUm and citrate concentrations were varied, 
artificial urines were prepared as described above, but the latter components were 
decreased or omitted (see table 4.2). 
Table 4.2. Artificial urine solutions prepared for crystallization experiments 
,...-..... 
• Solution IV Solution V Solution VI Solution VII 
I Artificial urin e Artificial urine Artificial urine from Artificial urine where 
from which which citrate is magnesium and citrate 
magnesIUm IS omitted concentrations are 
omitted reduced to 0.001 M and 
0.0008M respectively. 
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4.2.3. Urine samples 
Fifteen 24 h urine samples (solution VIII) were collected from healthy white male 
South African volunteers. THM and cellular debris were removed by filtering first with 
a pre-filter and then with a 0.45 J.-lm tilter paper. The pH and metastable limit of eaeh 
sample were measured. 
The CaOx metastable limit (corresponding to the concentrations of Ca+ and C20/- at 
which spontaneous nucleation and growth occur) was measured using the method of 
Ryall et al. (1985). 2.68 g of NaOx was dissolved in 100 ml water to prepare a 0.2 M 
solution. This stock solution was used to prepare a series of 13 dilutions with 
concentrations ranging from 0.015 to 0.195 M with incremental concentrations of 
0.015 M. A series of vials each containing 20 ml filtered urine samples were incubated 
at 37°C for 10 min. 100 J.-li of each dilution was added progressively to each vial at 
3 min intervals and the particle number was recorded 30 min thereafter using a Coulter 
Counter (model 5.sT.II, England). The NaOx concentration at which the particle 
number increased abruptly was taken as a measure of the MSL. 
Since polymer particles are large enough to block the aperture of the Coulter Counter, a 
HACH ratio turbidimeter (model 18900, USA), calibrated against the Courier Counter, 
was used to measure the metastable limits of urines to which the unimprinted and 
imprinted polymers had been added. 
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4.3. Preparation of functional monomer and imprinted polymers 
4.3.1. Preparation of 6-methacrylamidohexanoic acid 
The functional monomer, maaha, was prepared based on the Schotten-Baumann 
procedure (Mann and Saunders, 1967) from 6-aminohexanoic acid and methacrylic 
anhydride. The reaction (figure 14) involves nUcleophilic attack by the lone pair of 
electrons on the 6-aminohexanoic acid nitrogen at the electron deficient carbonyl 
carbon atom of methacrylic anhydride, followed by deprotonation of the amine group. 
3.67 g 6-aminohexanoic acid (1) was dissolved in a 10% (m/v) NaOH solution (25 ml). 
Methacrylic anhydride (2) (3.4 ml) was added and the reaction mixture was stirred for 
24 hours. The solution was then acidified to pH 1 by adding concentrated Hel. Solid 
6-methacrylamidohexanoic (3) acid was isolated and purified by silica gel column 
chromatography. The column was packed with a mixture of 80g silica gel in petroleum 
ether and a 3-4 em layer of sand was packed on top of the column bed. The column was 
then eluted with a 20:80 (v/v) dichloromethane:ethyl acetate mixture which was added 
through separating funnel. Fractions (50 ml) were spotted on a thin layer 
chromatography plate and run with diethyl ether. The fractions containing only the 
desired product were retained, the solvent mixture was removed using a rotary 
evaporator and the product dried in vacuo. The dried product was characterized by 
'H NMR spectroscopy on a Varian VXR200 spectrometer (figure 22,p. 63). 
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(0 0 
~~:r -------Jl .. ~ ~~~COOH OH 0) \ H2N·~COOH 
(1 ) 
o 
~N~COOH 1 H (3) 
+ 
A(OH 
o 
Figure 14. Mechanism of the preparation of maaha 
4.3.2. Preparation of imprinted polymers 
The strategy for the preparation of imprinted polymer and the subsequent nucleation of 
calcium oxalate on the polymer is illustrated in figure 15 (p 55) and is based on the 
approach of D'Souza et al. (1999). Briefly, template COM crystals (0.75 g) were stirred 
in a 5 ml solution of 0.020 M maaha in chloroform in a sealed tube for 24 hours. 
Thereafter, 1.41 ml of dvb CAR grade, 80%) was added with 0.039 g of 
azo-biscyclohexanecabonitrile (abchc) polymerization initiator. The sample mixture 
was degassed, sealed under reduced pressure and allowed to react for 6 hours at 4 °C 
following photochemical initiation of polymerization. After gelation, the polymer was 
heated at 65°C for 15 hours to complete polymerization. The sample was then dried in 
vacuo and gently ground with mortar and pestle to produce particles with a diameter of 
about 100 flm. 
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Samples of COD imprinted polymer were produced using the same protocol, except 
COD crystals were used in place of COM. Unimprinted polymer was prepared in the 
absence of COM and COD. 
XRD, FTIR and SEM techniques were used to confirm the incorporation of CaOx into 
the imprinted polymers. 
/Functional monomer, maaha 
!~ monom 
A 
'-------,> 
CHCi),24h 
cavities reoccupied 
complex 
B 
'dvb,abch? 
MeOHlHcijC 
<CaOx (aq~ 
D 
polymer with cavities 
Figure 15. Schematic representation of molecular imprinting process. 
A) Self-assembly of functional monomer on the surface of CaOx crystals by 
incubating in chloroform solution for 24 hours. 
B) Co-polymerization of monomer with dvb in the presence of an initiator, abchc. 
C) Template removal by dissolution and washing with acidified methanol (2M 
HCI, final concentration). 
D) Specific nucleation of CaOx template crystals from a saturated solution of 
calcium oxalate, artificial urine, or real urine (solutions I to VIII). 
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4.3.3. Removal of template crystals by washing 
Template crystals were then removed by soaking the polymer in 100 ml methanol 
acidified with HCI (2M final concentration with respect to HCI) for 2 days. The crystals 
were then washed four times with the acidified methanol solution. Finally the polymer 
was washed with acetonitrile (x 3) and water (x 1) and then dried in vacuo. 
Complete removal of the template crystals from the imprinted polymers was confirmed 
by XRD, FTIR, SEM and atomic absorption spectroscopy (AAS) analyses. 
4.3.4. Nucleation of calcium oxalate on imprinted and un imprinted polymer surfaces 
Samples of imprinted and unimprinted polymers (0.1 g) were placed in a series of 
flasks. To each of these was added either 20 ml metastable CaOx solution (solutions I 
through III, table 4.1 p 50), 200 ml artificial urine (solutions IV though VII, table 4.2 p 
50) or 200 ml real urine (solution VIII). The flasks were sealed and then agitated at 
25°C for 36 hours before filtration through 0.22 J.lm filter. The polymer was washed 
thoroughly with water to remove any weakly attached crystals. 
Samples obtained using imprinted and unimprinted polymers were characterized by 
XRD, FTIR and SEM. 
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4.4. Characterization of samples 
All of the prepared crystals, the unwashed and washed samples of the imprinted and 
unimprinted polymers, as well as nucleated polymers were characterized by XRD, 
FTIR, SEM and AAS analyses. 
Powdered samples were packed into aluminium trays and x-ray powder diffraction 
patterns were measured using a Philips PW 1050/80 vertical goniometer in the 28 range 
12 - 40° with Cu Ka radiation of wavelength 1.5418A produced at 40 k V and 25 mAo 
In the XRD patterns, the peaks at 28 values greater than 37° were removed since the 
aluminium sample holder diffracts at 38°. Thus, one of the characteristic peaks of COM 
(20 38.4°) will not be shown in the XRD graphs. The d-spacings were compared with 
standard reference values (table 4.3) for COM, COD and COT (Sutor and Scheidt, 
1968; Deganello et al., 1981). 
Infrared spectra were recorded between 2000 and 450 cm- l on a Perkin-Elmer Paragon 
1000 FTIR spectrophotometer using KBr pellets. 200mg KBr, previously dried in an 
oven and kept in a desiccator was thoroughly mixed with 2mg of the sample in a mortar 
and pestle. The mixture was then transferred to an appropriate dye, and pressed at 3000 
kPa to form a pellet. The pellet was mounted in a holder and placed in the sample path 
of the spectrophotometer. 
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Table 4.3. Interplanar spacings and relative intensities of powder patterns of 
the three hydrates of calcium oxalate. 
* Calcium oxalate * Calcium oxalate ** Calcium oxalate 
monohydrate: dihydrate: trih "drate: 
d-spacing Relative £I-spacing Relative £I-spacing Relath'e 
(A) intensit}' (A) intensi/J' (A) intensity 
5.93 100 8.70 12 7.87 40 
5.79 25 6.31 } 100 6.70 20 4.64 7 6.15 5.50 100 
4.52 6 4.40 45 5.28 40 
3.78 } 3.89 14 4.99 60 3.76 13 3.67 8 4.79 20 
3.65 100 3.58 I 4.02 20 
3.00 10 3.38 2 3.75 20 
2.97 46 3.15 ,., 3.67 40 .) 
2.91 12 3.09 } 18 3.62 60 2.89 10 3.07 3.58 10 
2.84 14 2.81 20 3.43 20 
2.51 2 2.77 } 85 3.35 10 2.48 30 2.75 3.26 20 
2.41 5 2.41 14 2.84 100 
2.37 2 2.39 14 2.77 80 
2.34 90 2.33 10 2.74 40 
2.69 40 
I 
2.66 20 
2.64 40 
* Sutor and Scheidt 1968; ** Deganello et al. 1981 
For SEM, the powdered sample was sprinkled onto an aluminum stub that had been 
coated in carbon glue. The stub was then sputter coated with gold palladium. The 
samples were examined on a Leica S440 scanning electron microscope (Leica 
Cambridge Ltd, Cambridge, England) operating at an accelerating voltage of 10 kV, a 
working distance of 10 15 mm and a probe current of 20 30 pA. 
The SEM micrographs were also helpful for the examination of the cavities left after 
the removal of the template crystals and for the comparison of the surfaces of the 
imprinted, unimprinted and nucleated polymers. 
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CHAPTER FIVE - EXPERIMENTAL RESULTS AND DISCUSSION 
5.1. Template crystals and functional monomer 
5.1.1. Verification o/COM crystals 
The XRD pattern of the CaOx crystals prepared using the method described by Pak et al. 
(1975) with the d-spacings (labelled) is shown in figure 16. The diffraction peak 
assignments and the percentage composition of these crystals, based on the standard 
reference table (table 4.3, p 57) is summarized in table 5.1. The diffraction pattern exhibits 
all the peaks expected for COM and is devoid of peaks characteristic of COD or COT, 
indicating that the sample was 100% COM. 
700 
Z. 600 
.~ 500 
QJ 
:E 400 
~ 300 , 
i 200 ~ 
- I 
ti. 100 ~ 
12 
.90 
5.79 
17 22 
3.63 
2.96 
2.49 
27 32 37 
26 
Figure 16. XRD pattern of COM crystals prepared according to Pak et a/. (1975). 
d-spacings are expressed in A and e is the diffraction angle in degrees. 
Table 5.1. X-ray powder diffraction peak assignments and percentage composition 
of CaOx crystals prepared according to Pak et a/. (1975) 
d-sp~~ing ........ Assignme~t--l 
(A) 
5.90 COM 
5.79 COM 
3.77 COM 
3.64 COM 
2.98 COM 100% COM 
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The infrared spectrum of the CaOx erystals grown according to the method of Pak et al. 
is sho\\tTI in figure 17. Comparison with the characteristic bands previously reported 
(Bellanato et aI., 1973; Modlin and Davies, 1981) for COM (1590, 1370, 1320, 960, 
890,665, and 515 cm"l) confirms that the crystals were indeed COM. 
200 
150B 
c 
('G 
100-2 
o 
f/) 
50 .g 
I 1320 0 
1850 1650 1450 1250 1050 850 650 450 
wavelength (cm-1) 
Figure 17. Infrared spectrum of the COM crystals grown according to the 
method of Pak et al.(1975) 
Figure 18 shows the SEM micrographs of the CaOx crystals grown according to the 
method of Pak et al. at lower (a) and higher (b) magnifications. Although the 
morphology of these crystals is ill-defined, the coffin-like shape that has been 
previously reported for COM crystals (Khan, 1995) is evident, thereby providing 
further evidence in support of the formation of this particular hydrate. Furthermore, the 
bipyramidal morphology of COD crystals (Kim, 1982) and the layered morphology of 
COT crystals (Rodgers, 1999) are both absent indicating 100% purity of COM. 
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Figure 18. SEM micrographs of the COM crystals grown by the method of Pak 
et al. (1975) at low (x500, a) and higher (x2500, b) magnifications. The coffin-
like morphology is indicated by arrows. 
Thus, the XRD, FTIR, and SEM analyses support each other that the CaOx crystals 
grown by the method of Pak et af., were pure COM crystals and contained no other 
hydrates of CaOx. 
5.1.2. Verification a/COD crystals 
The XRD pattern of the CaOx crystals prepared according to the method of Brown 
et af. (1989) with the d-spacings expressed in A (labelled) and the diffraction angle, 
e in degrees is shown in figure 19. Table 5.2 summarizes the assignment of the 
prominent peaks and percentage composition of these crystals on the basis of the 
standard reference (table 4.3, p 57). The XRD pattern shows that the sample indeed 
consists of COD. 
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Figure 19. XRD pattern of COD crystals prepared according to Brown et al. (1989) 
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Table 5.2. X-ray powder diffraction peak assignments and percentage composition of 
CaOx crystals prepared according to Brown et al. (1989) 
d-spacing 
(A) 
6.15 
4.39 
3.90 
3.64 
3.08 i 
2.76 
Assignment 
COD 
COD 
COD 
COD 
COD 
COD 
> 
100% 
COD 
The FTIR spectrum for COD shows absorption at 1590, 1315, 780 and 520 and differs 
from that of COM in that it lacks the bands at 960, 890, and 665 and that the 520 bands 
are sharper for COM (BelJanato eta!., 1973; Modlin and Davies, 1981). Figure 20 
shows the FTIR spectrum for the CaOx crystals grown in the present study according 
to Brown et a!. (1989). Th is spectrum showed all of the characteristic bands of COD 
crystals. Bands characteristic of COM were absent. However, the presence of a weak 
(unassigned) band at 612 cm'l is indicative of a trace amount of impurity. 
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Figure 20. FTIR spectrum of COD crystals prepared according to the method 
of Brown et al_ (1989) 
SEM revealed the presence of single and aggregated COD crystals as well as sparse 
amounts of COT (figure 21). The failure of XRD to detect COT is indicative of the 
latter being present in very small quantities. 
COT 
crystal 
COD crystals 
Figure 21. SEM micrograph of the 
CaOx crystals grown by the 
method of Brown et a/. (1989). 
Thus, with the exception of a single COT crystal revealed in SEM, the crystal grown 
was confirmed to be pure by XRD, FfIR and SEM analyses. 
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5.1.3. Characterization of the functional monomer 
The prepared functional monomer used for this study was characterized by I H NMR 
spectroscopy (figure 22) on a Varian VXR200 spectrometer, (CD3C02C2DS, 200 MHz) 
o 1.53 (6H, m, CH2), 1.92 (3H, s, CH3), 2.32 (2H, t, J= 6.3 Hz, CHz), 3.29 (2H, q, J= 
5.8 Hz, CI-{z), 5.28 (1 H, d, J = 3.7 Hz, =CH), 5.65 (1 H, s, =CH), 6.02 (1 H, br s, NH). 
The peaks were compared with the estimated I H NMR peaks of the compound, 
6-methacrylamidohexanoic acid, from the "Chemdraw" program. All of the peaks of 
the prepared product corresponded to the Chemdraw values, showing that the prepared 
functional monomer was 100 % pure 6-methacrylamidohexanoic acid. 
H2' H4 
-N 3 I' S 
C H 3' 
H3' 
A 
r ~ 
H2 & 116 
H3&H5 
I-
~ ~ 
NI).. f-
--
-"" 
- - - - -
'1 
1 JJ~,,- \ol .II. V w ~ ...,,>.. 
i 
" i I I 'i I j II i i I I i I, iii I iii I i'll j lii" i t I iii i J iii iii j iii , iii i j f, i I 
Figure 22, H1 NMR spectrum of the prepared functional monomer 
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5.2. Imprinted and unimprinted polymers 
5.2.1. COM imprinted po(vmer 
The XRD pattern of unwashed COM imprinted polymer is shown in figure 23. The 
prominent peaks corresponded to the characteristic diffraction peaks of COM listed in 
table 5.1 (page 58). 
500 -,--------~- ........ ------........ ----
~ 
'iii 400 
c: 
~ 300 
~ 200 
:;:::; 
.!! 100 (I) 
3.64 
~ O~~··----··············~·-·~·-----T-------~ 
12 22 32 
28 
Figure 23. XRD pattern of unwashed polymer imprinted with COM 
The FTIR spectrum of the unwashed COM imprinted polymer is shown in figure 24. 
The characteristic bands (cm- l ) of COM crystals (expected) at 1615 (1590), 1365 
(1371),1316 (1320), 985 (960), 894 (890),779 (780),511 (515) are evident. 
,-------.-.--------... --~ 140 
120 (I) 
100 g 
80 ~ 
60 :s 
40 ! 
20 m 
r····--,--,--~ 0 
1850 1650 1450 1250 1050 850 650 450 
wavelength (cm-1) 
Figure 24. FTIR spectrum of unwashed polymer imprinted with COM 
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An SEM micrograph of unwashed COM imprinted polymer is shown in figure 25. The 
surface of the polymer is seen to be covered by numerous crystals. However, their 
morphological features are not obvious. 
Figure 25. SEM micrograph of a particle of unwashed COM imprinted polymer 
Thus, the data from XRD and FTIR experiments show that the COM template crystals 
have not been altered under the conditions in which the polymerisation reaction has 
been carried out. 
5.2.2. COD imprinted polymer 
The XRD pattern of unwashed COD imprinted polymer is shown ill figure 26. 
Although the peaks are not well-defmed, reflections characteristic of COD are 
indicated. Like in the COM imprinted polymer, the XRD pattern showed that the COD 
template crystals have not been altered under the conditions in which the 
polymerisation reaction has been carried out. 
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Figure 26. XRD pattern of unwashed COD imprinted polymer 
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Figure 27 shows the FTIR spectrum of the unwashed COD imprinted polymer. This 
spectrum shows the characteristic absorption bands (expected) for COD (cm- I ): 1620 
(1590), 1323 (1315), 792 (780) and 512 (520). 
200 
150 ~ 
I: 
IV 
100-€ 
512 ~ 50 ~ 
92 I 
~~-~~T--~-~---~-~ 0 
1875 1675 1475 1275 1075 875 675 
Wavelength (cm-1) 
475 
Figure 27. FTIR spectrum of unwashed COD imprinted polymer 
The SEM micrograph of the unwashed COD imprinted polymer (figure 28) shows the 
presence of numerous particles. However, their morphological features are not obvious. 
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Figure 28. SEM micrograph of unwashed COD imprinted polymer 
Thus, the XRD and FTIR analyses conftrm that the COD template crystals have not 
been changed by the conditions of the polymerization process. 
5.2.3. Unimprinted polymer 
Since the polymer is an amorphous material, the XRD pattern of the unimprinted 
polymer has no peaks (figure 29). The unimprinted polymer is better characterized by 
infrared spectroscopy (figure 30). The FTIR spectrum shows distinct and sharp 
absorption at 1598, 1441, 986, 900, 831, 792 and 707 cm- I . The SEM micrograph of 
this material is shown in ftgure 31. Unlike the imprinted surfaces, the unimprinted 
polymer has a relatively smooth surface and has no crystal deposits. 
700 
~ 600 
II) 
I: 500 Q) 
-400 I: 
Q) 300 > ~ 200 IV 
a; 100 0:: 
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12 22 32 
29 
Figure 29. XRD pattern of unimprinted polymer 
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Figure 30. FTIR spectrum of unimprinted polymer 
Figure 31. SEM micrograph of unimprinted polymer 
5.3. Removal of template crystals from imprinted polymers 
5.3.1. Washed COM imprinted polymer 
68 
The XRD pattern of the COM imprinted polymer after the acidified methanol wash shows 
no peaks, confirming that the imprinted template crystals have been completely removed 
(figure 32). The infrared spectrum (figure 33) also shows only the bands characteristic of 
the polymer, confirming complete removal of template COM crystals. The SEM 
micrographs of this material at low magnification (figure 34a) and higher magnification 
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(figure 34b) show that the washed polymer contains numerous vacant cavities that are casts 
of the original COM crystals. 
400 ~----------------------------, 
~ 
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.s 
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Figure 32. XRD pattern of washed COM imprinted polymer 
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Figure 33. FTIR spectrum of washed COM imprinted polymer 
Figure 34. SEM micrograph of washed COM imprinted polymer at low 
magnification (x 500, a) and higher magnification (x 2500, b). Vacant cavities 
(casts of COM crystals) are clearly evident. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
70 
Atomic absorption (AA) analysis was conducted on the COM imprinted and washed 
polymers using a Technics AA5 Spectrophotometer to detect whether any COM crystals 
remained after washing i.e., to measure the extent of removal of the template COM crystals 
from the polymer. From these analyses, it was demonstrated that at least 99.8% of the 
imprinted COM crystals had been removed from the polymer (table 5.3). 
Table 5.3 Calcium content of 0.200 g samples of unwashed and washed COM 
imprinted polymer 
Ca in unwashed 
polymer (mg) 
46.48 ± 0.02 
Ca in washed 
polymer (mg) 
0.074 ± 0.004 
5.3.2. Washed COD imprinted po{vmer 
% Ca remaining 
after washing 
0.16 ± 0.01 
Figure 35 shows the XRD pattern of the acid-washed COD imprinted polymer. No peaks 
were observed in this XRD pattern showing complete removal of the imprinted COD 
template crystals from the polymer. None but the polymer bands were observed in the 
FTIR spectrum of the washed COD imprinted polymer (figure 36). The SEM micrograph 
of the washed COD imprinted polymer is shown at low magnification in figure 37a and at 
greater magnification in figure 37b. Cavities (corresponding to COD crystals) are evident. 
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Figure 35. XRD pattern of washed COD imprinted polymer 
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Figure 36. FTIR spectrum of washed COD imprinted polymer 
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Figure 37. SEM micropgraphs of washed COD imprinted polymer at low 
magnification (x500, a) and higher magnification (x 5000, b) 
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The results of AA analysis, like those of the washed COM imprinted polymer, showed the 
removal of at least 99.8% of the CaOx present in the unwashed COD imprinted polymer 
(table 5.4). 
Table 5.4. Calcium content of 0.200 g samples of unwashed and washed COD 
imprinted polymer 
Ca in unwashed 
polymer (mg) 
41.49 ± 0.02 
Ca in washed 
polymer (mg) 
0.055 ± 0.004 
% Ca remaining 
after washing 
0.13 ± 0.01 
Thus, the XRD, FTIR and SEM experiments together with the AA analyses confirmed that 
the washed COD imprinted polymer was free of the template crystals. 
5.4. Effect of imprinted polymers on CaOx precipitation 
The effect of COM and COD imprinted polymers on CaOx precipitation will be 
discussed in this section. Unimprinted polymer is used as a control to compare the 
effect of the imprinted polymers. Control solutions are also used in the absence of any 
polymer for the same reason. Table 5.5 provides a summary of the results obtained 
from all of the experiments. 
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Table 5.5. Summary of the XRD patterns of crystallization experiments. 
Metastable CaOx Solutions 
II III IV 
I ~ontrol Solution Fig. 48 No detectable crystallization BRU 
~'. ~~ 38 I Fig. 39 I ~g. 40 I 
.r1nt"A Unimp •. uw ... 
Polymer 
Fig. 52 
No evident crvstallization-~ BRU 
COM-Imprinted 
Polymer 
~ Fig. 42 
COM I COM 
I 
I COD-Imprinted F.~-F' " 
Polymer 
No crystals I COM and 
COD 
Fig. 43 Fig. 56 
COM I COM 
Fig. 60 
COM and 
BRU 
Fig. 69 Fig. 70 
COD I HAP and 
. traces of 
~CO~COD & COT 
Solutions of Artificial urine Real Urine 
V VI VII VIII .~----
FIg. 49 F.~~~g. 61 
I 
HAP and 
traces of COD 
I BRU and ,. BRU and traces I BRU 
traces of of COD 
COM & 
COD 
Fig. 53 Fig. 54 
I HAP and COD I BRU and 
I· (trace) I traces of COM and 
j COD 
Fig. 57 Fig. 58 
COM COM 
I 
I 
Fig. 55 
BRUandCOD 
(trace) 
Fig. 59 
COM 
~Fig.72 ~g.7J 
HAP and I BRU and BRU and COD 
traces of COD I traces of 
and ARAG COM, COD 
and COT 
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Solutions I to VII are discussed in tables 4.1 and 4.2 (p 50) and solution VIII is urine from healthy white South African volunteers. 
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5.4.1. Precipitation/rom CaOx solution on COM imprinted po~vmer sur/ace 
Table 5.5 shows that there was no spontaneous precipitation of any crystals in solutions 
I to III. There also occurred no evident crystallization when the unimprinted polymer 
was soaked in these three solutions (XRD pattern; figures 38 to 40). Figures 41 to 43 
show XRD pattern of crystals which precipitated on COM imprinted polymer from 
solutions I to III respectively. Diffraction peaks due to COM are evident in all of them, 
including solution III in which the calcium-to-oxalate ration favours COD formation. 
The presence of precipitated COM on the washed imprinted polymer and its absence 
on the unimprinted polymer was also evident from FTIR (figures 44 and 45). In 
addition, SEM showed that the cavities on the surface of the washed imprinted polymer 
were reoccupied by a mass of small crystals (figure 46), but almost no deposition was 
observed on the surface of the unimprinted polymer (figure 47). Finally AAS 
(Table 5.6) data show that more than 50% of the calcium present in the solution 
precipitated on the surface of imprinted and washed polymer while negligible 
quantities were detected on the surface of the unimprinted polymer. Moreover, there 
was no precipitation in the absence of any polymer. It is therefore concluded that the 
imprinted polymer directs nucleation of calcium oxalate crystals from a metastable 
solution, a solution in which no spontaneous precipitation occurs. 
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Figure 38. XRD pattern of unimprinted polymer soaked in 0.003 M CaOx 
solution 
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Figure 39. XRD pattern of unimprinted polymer soaked in 0.005 M CaOx 
solution 
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Figure 40. XRD pattern of unimprinted polymer soaked in CaOx solution with 
4: 1 calcium to oxalate ratio 
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Figure 41. XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in 0,003 M CaOx solution (Le., Solution I) 
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Figure 42. XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in 0.005 M CaOx solution (i.e., Solution II) 
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Figure 43. XRD pattern of COM precipitated on washed COIVI imprinted 
polymer after soaking in a solution with 4:1 calcium-to-oxalate ratio (Le" 
Solution III) 
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Figure 44. FTIR spectrum of washed COM imprinted polymer after soaking in 
0.003 M CaOx solution (i.e., solution I) (Peak enlargement at 1314 and 1612 is 
due to COM) 
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Figure 45. FTIR spectrum of unimprinted polymer soaked in 0.003 M CaOx 
solution (i.e., solution I) (The absence of peaks at 1314 and 1612 cm-1 
indicates the absence of COM). 
Figure 46. Washed COM imprinted 
polymer soaked in solution I. 
Heavy crystal deposits in the 
cavities are evident. 
Figure 47. Unimprinted polymer 
soaked in solution I. Very little 
crystal deposition has occurred. 
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Table 5.6. Percentage of calcium precipitated from 0.020 I of 0.003 M CaOx 
solution on unimprinted and washed COM imprinted polymers. 
% Ca precipitated on COM 
imprinted polymer 
55.8 ± 0.4 
% Ca precipitated 
unimprinted polymer 
0.44 ± 0.05 
5.4.2. Precipitation from artificial urine on COM imprinted po{vmer surface 
When artificial urine (i.e., solution IV) was agitated at 25°C tor 36 hours in the absence of 
all polymers and in the presence of unimprinted polymer, brushite (CaHP04.2H20) 
precipitated spontaneously. This is shown by the XRD spectra, in figures 48 and 52 
respectively. The characteristic peaks of brushite (BRU) were obtained from Sutor (1968). 
However, in the presence of the washed COM imprinted polymer, pure COM crystals were 
nucleated as demonstrated in the XRD spectrum shown in figures 56 to 59, but in some 
instances brushite precipitated simultaneously (XRD spectrum, figure 60). Neither COM 
alone nor the mixture of COM and brushite precipitated spontaneously. 
When magnesIUm was omitted from the artificial UrIne (i.e., solution V) pure COM 
crystals precipitated on the surface of washed COM imprinted polymer, but there were 
cases in which hydroxyapatite (HAP), CalO(P04)6(OHb precipitated simultaneously. COD 
and hydroxyapatite (HAP) precipitated from this solution in the absence of any polymer 
and when unimprinted polymer was soaked in it. COM precipitated on the surface of 
washed COM imprinted polymer soaked in artificial urine prepared without citrate 
(i.e., solution VI). Under conditions where the concentrations of both magnesium and 
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citrate were reduced to 25% of those in solution IV, traces of COD and brushite 
precipitated in the absence of all polymers and when there is unimprinted polymer. 
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Figure 48. XRD pattern of brushite spontaneously precipitated from synthetic 
urine (i.e., solution IV) 
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Figure 49. XRD pattern of HAP precipitated from artificial urine from which 
magnesium is omitted (i.e., solution V) (also contains traces of COD) 
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Figure 50. XRD pattern of BRU precipitated from artificial urine prepared 
without citrate (i.e., solution VI) (contains traces of COM and COD) 
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Figure 51. XRD pattern of BRU precipitated from artificial urine in which 
concentrations of magnesium and citrate were reduced to 25% of those in 
solution IV (Le., solution VII) 
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Figure 52. XRD pattern of brushite precipitated on unimprinted polymer after 
soaking in artificial urine (i.e., solution IV) 
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Figure 53. XRD pattem of HAP precipitated on unimprinted polymer after 
soaking in artificial urine without magnesium (Le., solution V) (contains COD) 
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Figure 54. XRD pattern of BRU precipitated on unimprinted polymer after 
soaking in artificial urine without citrate (Le., solution VI) (contains traces of 
COM and COD) 
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Figure 55. BRU precipitated on unimprinted polymer after soaking in artificial 
urine in which the concentrations of magnesium and citrate are quartered (Le., 
solution VII) (contains traces of COD) 
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Figure 56. XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in synthetic urine (Le" solution IV) 
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Figure 57, XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in artificial urine in the absence of magnesium (Le., 
solution V). 
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Figure 58, XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in artificial urine without citrate (Le., solution VI). 
~ 400 .. ,----. 
'iii 
c:: 300 
J!l 
.E 200 (I) 
> ~ 100 
(I) 
ct: o+---,---,------------,~ 
12 17 22 27 32 37 
29 
Figure 59. XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in artificial urine in which the concentrations of 
magnesium and citrate were reduced to 25% of those in solution IV (Le., 
solution VII). 
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Figure 60. XRD pattern of a mixture of COM and brushite precipitated on washed 
COM imprinted polymer after soaking in synthetic urine (Le., solution IV). 
5.4.3. Precipitation from real urine on COM imprinted polymer surface 
As with artificial urine, brushite usually precipitated spontaneously when real urine was 
agitated at °c for 36 hours in the absence of all polymers (XRD spectrum: figure 61) 
and in the presence of unimprinted unimprinted polymer (XRD spectrum: figure 62). In 
most cases where the washed COM imprinted polymer was soaked in urine, both COM 
and brushite precipitated simultaneously (XRD spectrum: figure 64). In one case, COM 
precipitated exclusively from the urine with no brushite being formed (XRD spectrum: 
figure 63). Neither COM alone nor simultaneously precipitated spontaneously from urine 
unless the washed COM imprinted polymers is soaked in it. 
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Figure 61. XRD pattern of brushite spontaneously precipitated from urine (i.e., 
solution VIII) 
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Figure 62. XRD pattern of brushite precipitated on unimprinted polymer after 
soaking in real urine (i.e., solution VIII) 
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Figure 63. XRD pattern of COM precipitated on washed COM imprinted 
polymer after soaking in real urine (i.e., solution VIII) 
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Figure 64. XRD pattern of a mixture of COM and brushite precipitated on 
washed COM imprinted polymer after soaking in real urine (i.e., solution VIII) 
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5.4.4. Effect of COM imprinted po{vmer on the CaOx metastable limit of urine 
The MSLs of five urine samples from white healthy South African volunteers were 
measured by the method of Ryall et al. (1985) using the Coulter Counter. Four of these 
were found to be 0.045 M (figure 65). 
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Figure 65. Determination of MSL of urine using Coulter Counter 
MSL of five samples of urine were determined in the presence of imprinted and 
unimprinted polymers. The COM imprinted polymer brought about a decrease in the 
MSL of four of these, while the unimprinted polymer had no effect. An example is 
shown in figure 66. A Turbidimeter was used for this determination because the 
polymer particles are large enough to block the aperture of the Coulter Counter. The 
turbidimeter was calibrated against the Coulter Counter and counts were multiplied by 
the calibration factor. 
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Figure 66. Effect of COM imprinted polymer on MSL 
5.4.5. Precipitation/rom CaOx solution on COD imprinted polymer sUrface 
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In contrast to the COM imprinted polymer, the COD imprinted polymer did not direct 
nucleation of pure COD crystals. Crystallization did not occur when the washed COD 
imprinted polymer was soaked in 0.003 M CaOx solution (XRD spectrum: figure 67). 
However, COM with small amounts of COD precipitated from 0.005 M CaOx solution 
(XRD spectrum: figure 68). Pure COD crystals with traces of COT precipitated only 
when a solution with a 4: 1 calcium-to-oxalate ratio was used (XRD spectrum: 
figure 69). The AA analysis in table 5.7 shows that the COD imprinted polymer, like 
the COM imprinted one facilitated the precipitation of CaOx crystals but it did not 
specifically direct nucleation of pure COD crystals. 
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Figure 67. XRD pattern of washed COD imprinted polymer soaked in 0.003 M 
CaOx solution (Le., solution I) 
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Figure 68. XRD pattern of a mixture of COM and COD precipitated on washed 
COD imprinted polymer after soaking in 0.005 M CaOx solution (Le., solution II) 
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Figure 69. XRD pattern of COD and traces of COT precipitated on washed 
COD imprinted polymer after soaking in a solution with 4:1 calcium-to-oxalate 
ratio (Le., solution III). 
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Table 5.7. Percentage of calcium precipitatedfrom 0.020 I of 0.003 M CaOx 
solution on unimprinted and washed COD imprinted polymers. 
% Ca precipitated on 
COM imprinted polymer 
52.3± 0.4 
% Ca precipitated on 
unimprinted polymer 
0.44 ± 0.05 
5.4.6. Precipitation from artificial and real urines on COD imprinted po(vmer 
surface 
In most of the cases where the washed COD imprinted polymer was soaked in artificial 
urine, brushite precipitated with traces of COD. There were many cases where all the 
three hydrates of calcium oxalate precipitated out (XRD spectrum: figure 70). When 
magnesium was made absent from the artificial urine (solution V), COD with traces of 
HAP and aragonite, CaC03, (ARAG) precipitated on the surface of washed COD 
imprinted polymer (XRD spectrum: tigure 71). HAP and traces of all the three hydrates 
of CaOx precipitated from artificial urine prepared without citrate (solution VI) (XRD 
spectrum: figure 72). And when the concentrations of magnesium and citrate were 
reduced to quarter of those in solution IV (i.e., solution VII), brushite precipitated with 
traces of COD (XRD spectrum: figure 73). Brushite was precipitated almost 
exclusively when washed COD imprinted polymer was soaked in real urine (XRD 
spectrum: figure 74). 
Unlike the COM imprinted polymer, the COD imprinted polymer did not direct 
specific nucleation of COD crystals from both artificial and real urines. 
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Figure 70. XRD pattern of solid precipitated on washed COD imprinted 
polymer after soaking in synthetic urine (Le., solution IV) 
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Figure 71. XRD pattern of solid precipitated on washed COD imprinted 
polymer after soaking in artificial urine without magnesium (i.e., solution V). 
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Figure 72. XRD patter of solid precipitated on COD imprinted polymer after 
soaking in artificial urine without citrate (Le., solution VI). 
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Figure 73. XRD pattern of solid precipitated on washed COD imprinted 
polymer after soaking in synthetic urine with magnesium and citrate 
concentrations reduced to 25% of those in solution IV (i.e., solution VII). 
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Figure 74. XRD pattern of brushite precipitated on washed COD imprinted 
polymer after soaking in real urine (i.e., solution VIII). 
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CHAPTER SIX- DISCUSSION 
Molecular recognition by molecularly imprinted polymers usually involves a careful 
balance between rigidity and flexibility of the polymer. If it is too flexible, the recognition 
site does not survive removal of the template molecule, while if it is too rigid the entropy 
cost of binding a guest molecule at the recognition site is too high (Wulff, 1995). For this 
reason, relatively small quantities of cross-linking agents are normally used (Wulff, 1995). 
The discovery by D'Souza et al. (1999) that the highly rigid maahaldvb co-polymer can 
specifically nucleate calcite crystal formation has opened a way to study biomineralization 
processes using such rigid molecularly imprinted polymers. The present study has shown 
that the same polymer is also capable of nucleating both COM and COD crystallization 
from aqueous, supersaturated solution of CaOx. This suggests that the co-polymer may 
also be useful for nucleating the crystallization of other calcium salts, and rigid polymers 
may thus be of quite general utility in the formation of solids. 
[t is essential that studies of molecularly imprinted polymers demonstrate adequately that 
the activity of the polymer is a result of the imprinting process. Thus multiple analytical 
techniques (XRD, FTIR, SEM and AAS) were employed in the present study and several 
control experiments were included to demonstrate that nucleation of CaOx crystallization 
is specific to the imprinted polymer. 
Firstly, XRD and FTIR clearly showed that neither COM nor COD precipitation occurs 
spontaneously in any of the solutions investigated under the experimental conditions used. 
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Secondly, neither COM nor COD crystallization was induced from supersaturated CaOx 
solutions, artificial urine or real urine in the presence of the unimprinted polymer. 
Formation of COM and COD on the imprinted polymer is thus certainly not spontaneously 
brought about by the polymer itself. It could be argued that COM or COD crystals trapped 
in the polymer are responsible for nucleating the formation of these solids. However, this 
seems unlikely since no crystalline material was detected in the washed polymers using 
XRD and no CaOx was discernible in the washed polymer by FTIR. Moreover, AAS 
indicated that more than 99.8% of the calcium originally present in the unwashed, 
imprinted polymer had been removed in the washing process. 
The conclusion that the molecular imprints on the surface of the cavities in the polymer 
produced in the imprinting process are responsible for nucleating COM crystallization is 
supported by SEM, which indicates that these cavities become filled with COM crystals. 
Similar to calcium carbonate, the present method was more effective for one crystal form 
than for another. In the case of calcium carbonate, D'Souza et af. (1999) showed that 
calcite, but not aragonite crystallization can be nucleated on the suitably imprinted polymer 
surface. In the present case of CaOx, both COM and COD crystallization can be induced 
on the appropriately imprinted surface, but only the COM imprinted surface nucleates 
formation of pure material. These results show that the COD imprinted surface appears to 
have induced both COD and COM crystallization, with the former being present in only 
trace amounts. It is possible that COD crystals were initially nucleated but then involved 
in a rapid transformation to the thermodynamically more stable COM. This hypothesis 
agrees with the findings of Gardner (1976) who suggested that COT undergoes a solid-
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state transformation to COD and COM. Indeed, the presence of COT was detected in one 
of the SEM micrographs (figure 21) and FTIR (figure 20). The COT disappeared after the 
polymerization reaction (figure 26). Conversely, Brecevic et al. (1986) suggested that the 
transformation is a solution-mediated process. The appearance of COT when a washed 
COD imprinted polymer was soaked in a solution mixture of 0.0 12 M CaCh and 0.003 M 
NaOx is in agreement with the latter proposal. 
The pH dependent precipitation of brushite is well known and the critical range is reported 
to be above 5.5 (Ackerman, 1987). In the present study, the pH of the artificial urine was 
6.S while the pH of the real urines varied from 4.83 to 6.71. Thus, the formation of 
brushite can be attributed to the relatively high pH of the solutions, rather than to the 
imprinted polymer. However, it is noteworthy that despite the strong influence of pH in 
directing brushite formation, COM was nevertheless nucleated on the COM-imprinted 
polymer. 
As mentioned in chapter one of this thesis, heterogeneous nucleation is the most likely 
mechanism by which crystals form in the urinary tract (Finlayson, 1978). In this process 
nucleation is induced on a foreign surface present in the crystallization medium. Human 
urine contains several such surfaces, cellular debris and sloughed-off epithelial membranes 
(Hess and Kok, 1996), while the walls of the urinary tract itself might provide a site 
(generally the papillae) for crystal formation (Grases et al., 1994). The present study raises 
the interesting possibility that CaOx crystals may leave a lesion on the surface of the 
kidney as the cells around the retained crystals grow or as some of the protective lining 
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cells are damaged due to infection. After the retained crystal is removed by either excretion 
(before it grows to form a stone) or medical treatment, the remaining cavity may act as a 
catalytically active center and may reduce the activation energy for the precipitation of 
further crystals. But this is less likely to happen because of the continuous turning over of 
the epithelial cells. Several workers have recognized the importance of studying the early 
stages of CaOx crystallization using models that try to reproduce in vivo conditions. 
Substrates include renal epithelial cells (Lieske and Toback, 1993), rat renal papillary tip 
collecting duct cells (Mandel and Riese, 1991) and renal tubular brush border membrane 
rat vesicles (Khan et at., 1993). In addition, some investigators have used a foreign surface 
immersed in urine-like systems to characterize CaOx crystallization processes. Amongst 
these surfaces have been self-assembled monolayers containing derivatized organic 
functional groups (Campbell, 1993), molten wax (Grases et aI., 1994) and the urothelium 
of pig urinary bladder (Grases et aI., 1996). Thus, the use of an imprinted polymer in the 
present study provides yet another model for such investigations. 
It is of some interest that a study by Geider et ai. (1996) demonstrated that calcium 
carbonate (calcite) nucleated the epitaxial crystallization of CaOx. As such, it is perhaps 
not surprising that the co-polymer used in the present study was able to successfully 
nucleate CaOx, as it had previously been used for the nucleation of calcium carbonate 
(0' Souza et aI., 1999). 
The present study has demonstrated that the mere presence of a suitable surface can induce 
crystallization of COM and COO, even from highly complex solutions such as urine. 
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Indeed, COM crystallization occurred from the urme of a healthy subject without 
modification of the urine itself having been made. While one cannot draw any definite 
conclusions about the physiological precipitation of CaOx from this observation, it does 
demonstrate that it is feasible for a substrate surface to crystallize CaOx from normal urine. 
This seems to lend some support to the hypothesis that CaOx stone formation is brought 
about by abnormal ities in the epithelium or by the presence of suitable nucleating proteins. 
This appears possible even in the absence of any changes in urine composition. 
The metastable limit of the urine samples from healthy white South African male subjects 
was observed to be 0.45 mM. Introducing COM and COD imprinted polymers reduced this 
value to 0.30 mM, whereas the control polymer did not change the MSL. This suggests 
that the imprinted polymers provided preformed surfaces and acted as heterogeneous 
nucleators. 
The protocol described in this study may provide an additional diagnostic tool for stone 
researchers to determine the "stone forming risk" of a particular urine and it could thus be 
added to the existing array of protocols. It is suggested that it may be superior because 
urine composition is not altered in the work-up for the test. Determination of the CaOx 
metastable limit (Ryall et at., 1985) or the Bonn-risk index (Laube et aI., 2000) requires 
chemical manipulation of the urine under investigation, whereas the imprint test utilizes 
urine in its natural voided state. It will thus be of considerable interest to determine 
whether the urine of stone formers is more susceptible to CaOx crystallization than that of 
healthy controls using the molecularly imprinted polymer model described in this study. 
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In conclusion, the present study has demonstrated that a maahaldvb co-polymer imprinted 
with either COM or COD is capable of nucleating the formation of either of these solids 
from various CaOx solutions, including urine. This provides an interesting model system 
for further investigation of CaOx biomineralization. 
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CHAPTER SEVEN - CONCLUSION AND FUTURE WORK 
The present study strongly suggests that heterogeneous nucleation is the decisively 
important mechanism in the process of kidney stone formation. The crystallization of 
CaOx from (i) metastable CaOx solutions of different concentrations (solutions I through 
III, table 4.1 p 50), (ii) artificial urine with varying concentrations of magnesium and 
citrate (solutions IV through VII, table 4.2 p 50) and (iii) real human urine on the surface 
of a molecularly imprinted polymer (maaha) is in agreement with the above hypothesis. 
XRD, FTIR, SEM and AA experiments demonstrated that maaha imprinted with COM and 
COD crystals directs nucleation of specific crystals from aqueous supersaturated CaOx 
solutions of different concentrations at metastability. This probably happened because the 
imprints in the polymer reduce the metastable limit of the solutions with respect to CaOx 
by providing preformed surfaces for crystal nucleation and growth. 
When the polymers imprinted with COM and COD crystals were immersed in artificial 
urine in which the magnesium and citrate concentrations were varied, only the COM 
imprinted polymer directed nucleation of COM crystals and brushite without formation of 
COD, whereas the COD imprinted polymer led to precipitation of a mixture of many 
crystals containing mainly COM, COD and brushite. From this observation it can be 
suggested that magnesium and citrate inhibit the formation of CaOx crystals and that their 
effect seems to be additive. Furthermore; magnesium seems to inhibit better in the 
presence of citrate. The reason that only the COM imprinted polymer has directed 
nucleation of pure COM crystals could possibly be because of the greater thermal stability 
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of COM crystals, as a result of which the COD crystals might have been transformed to 
COM during the course of the reaction, or formed directly from the solution. It could also 
be because of the more negative surface charge of the COM crystals compared to COD 
crystals. 
Both the COM and COD imprinted polymers lowered the metastable limit of human urine 
whereas the control polymer did not change it at all. When it comes to nucleation, only 
COM imprinted polymer (in some cases) led to the nucleation of pure COM crystals 
(although in most cases COM and brushite was formed). The COD imprinted polymer and 
the control polymer precipitated almost exclusively brushite. 
This study concludes that heterogeneous nucleation is the process that plays determining 
role in the process of stone formation and that the imprinted polymer model may be used 
as a diagnostic tool in stone-risk assessment in urine. 
The results of this thesis show the fulfillment of the objectives of the study. However, 
future studies should address the following. Firstly, additional concentrations of metastable 
solutions of CaOx must be considered in order to determine the smallest concentration that 
leads to nucleation of pure CaOx crystals on the surface of the imprinted polymers. 
Secondly, more combinations of varying concentrations of magnesium and citrate need to 
be studied in order to study how they affect each other and to investigate the ability of 
various ions to inhibit or promote CaOx crystal nucleation on the imprinted polymer 
surface. Thirdly, urine samples from stone-formers should be included in future studies, 
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since the present study comprised only non stone-formers. It would be of interest to 
investigate differences between the two groups with respect to CaOx nucleation. However, 
in the present study, only aqueous solutions reproducibly led to nucleation of pure CaOx 
crystals but not human urine. It may thus be necessary to find ways to inhibit brushite 
formation in order to study CaOx crystallization in urine using this system. The effect of 
urinary macromolecules and other ions present in urine on the crystallization of CaOx 
crystals on the surface of molecularly imprinted polymers could also be investigated. 
Lastly, an effort could be made to develop standardized assay for determining stone 
formation risk in urine samples using molecularly imprinted polymers. 
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